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                                       Abstract 
Functional nanocomposites have attracted a great deal of attention from scientists and 
engineers for reasons well beyond the scope of their appealing structures, tuneable 
physical and chemical properties. Benefitting from their extraordinary properties such 
as small particle size, hierarchical nanostructures, controllable surface properties, 
multi-component nanocomposites can offer new opportunities for biomedical 
applications including disease diagnosis, drug/gene delivery, biosensors, tissue 
engineering, and cancer therapy. As an interdisciplinary research area that integrates 
biology, chemistry, materials science, engineering and nanotechnology, over the past 
decades, rapid advances have been made in nanomedicine. Currently, many research 
attempts have focused on the development new nanocomposites with tuneable surface 
properties and multiple functionalities, which have evolved new generation 
nanomaterials for biomedical applications. However, it is still desirable for the design 
of nanocomposites with multicomponents and controllable surface properties for 
intensive biomedical study; for example, engineering of nanocomposites for 
investigation of the nano-bio interface to mimic the natural system such as enzyme or 
virus. The aim of this thesis is to mimic the nanostructure in the natural system, to 
design and fabricate nanocomposites with suitable composition, and alter their surface 
properties and structure to suit the target biomedical applications. The main 
achievements obtained in this thesis are listed below. 
 
    In the first part, a facile method has been developed for preparation of magnetic 
mesoporous silica core-shell nanocomposites with large void pores and tuneable 
particle sizes. The spherical particle size can be tuned from 110 nm to 800 nm by 
tailoring the synthesis parameters such as ethanol to water volume ratio, while the 
large void pore on shell can be regulated from 8.0 to 20 nm by increasing the amount 
of ethanol. By further surface engineering with the NH2 group, the NH2-functionalized 
magnetic mesoporous silica nanospheres could be efficiently internalized into HeLa 
cell lines, which is potentially important for siRNA efficacy against cancer cells. The 
results would provide an application paradigm of magnetic mesoporous silica 




    In the second part, a mild synthesis method has been developed for preparation of 
periodic mesoporous organosilicas (PMOs) through a condensation  process of 
organosilicates 1,2-bis(trimethoxysilyl) ethane around inorganic-electrolyte-stabilized 
Pluronic F127 [(EO)106(PO)70(EO)106] triblock copolymer micelles. It is found that the 
addition of inorganic sulfate salts in the synthesis is a crucial factor to ensure the 
formation of ordered mesostructures. The addition of Na2SO4 and MgSO4 in the 
synthesis system can lead to the formation of ordered 2-D hexagonal (P6mm) and 3-
D cubic (Im3m) mesostructures, respectively. The mechanism for PMOs formation 
has been proposed on the basis of inorganic salts assisted micelles-organosilicates 
closed packing under mild synthetic condition. The findings from this work contribute 
fundamental understanding towards a new formation route of these ordered 
mesoporous materials. This provides a new strategy to fabricate mesoporous silicas 
with controllable structures for emerging biomedical applications, for example, in-
situly load the guest molecules such as enzyme or drug into the matrix. 
 
    In the third part, a facile and novel protocol has been developed to synthesise AgNPs 
in various microbe culture broths. The broth ingredients provide an ideal environment 
for the formation of AgNPs with uniform size distribution. The significant influences 
of some important parameters include light condition and broth pH values have been 
investigated systematically. Whilst sharing similar advantages with the conventional 
microbial processes to use non-hazardous chemicals, this method is of particular 
importance as it employs the culture broth alone without involving any specific 
microorganism. 
 
    In the fourth part, we have successfully prepared raspberry-like mesoporous silicas 
with particle size of 360 nm through an extension of the Stöber process. By precisely 
controlling the synthesis parameters, either decreasing the CTAB concentration or 
increasing the amount of TEOS, multi-compartment silicas with mesoporous silica 
spheres bridged with mesoporous silica rods can be fabricated. It is found that the 
particle size of mesoporous silica can be tuned from 100 to 600 nm with 2 nm hollow 
silica nanoparticles doped on the surface, which can be achieved by varying the water 
to ethanol ratio. Specifically, the present strategy allows an easy way to generate the 
hierarchical nanostructured silicas by mimicking the structures of diatom cells for the 
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potential application in catalysis and nanomedicine. Further studies are currently in 
progress in order to probe their efficiency in gene therapy and anti-aging applications. 
 
    In the fifth part, we have successfully prepared hollow colloidal carbon 
nanostructures with raspberry-like morphology. The developed method is highly 
reproducible and straightforward to synthesize uniform hollow colloidal carbon 
nanostructures with controllable surface properties and Janus particles. The 
water/ethanol ratio of the solvent is a critical factor in determining the different surface 
properties. After a thorough systematic investigation, we found the formation of 
different morphologies of silica@RF is due to the solubility difference of CTAB in 
different solvents. Furthermore, the as-prepared raspberry-like HCCNs display 
superior performance to smooth HCCNs in the LDI-MS detection of peptides, which 
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Chapter 1. Introduction 
1.1 Significance of the project 
In the past decade, with the progress in nanotechnology, biomedicine and 
nanopharmaceutics, “theranostics”, which is the combination of diagnosis and therapy, 
has received burgeoning scientific and clinic attention.[1-5] The target of 
“nanotheranostics” is to develop multifunctional nanocarriers with hierarchical 
structures and that can integrate diagnostic and therapeutic functions into one 
nanoparticle.[3-5] To achieve this goal, as shown in Figure 1.1[5], diverse type of 
organic (e.g., polymer, micelles, liposomes, vesicles and dendrimers) or inorganic 
(e.g., silicas, carbons, metal oxides) nanocarriers have been developed for loading or 
encapsulating biomedical “payloads”. These include therapeutic agents (anticancer 
drugs, DNA, small interfering RNA [siRNA], proteins, hyperthermia-inducing 
nanoparticles, ROS-generating agents, etc.) and imaging agents (e.g., organic dyes, 
quantum dots [QDs], upconversion particles [UCNPs], MRI contrast agents, CT 
contrast agents, etc.). The key requirements for the nanocarriers are as follows: 1). high 
loading capacity for the biological payloads; 2). sufficient physical protection for the 
imaging agents; 3). controlled release for the therapeutic agents; 4). high 
biocompatibility/low toxicity; 5). easy surface modification for additional properties 
of nanotheranostics. 
Figure 1.1 Various organic/inorganic carriers for biomedical applications. [5] 
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    Compared to conventional nanocarriers, multicomponent silicas or carbons have 1). 
special porous structure and high surface area for loading higher amounts of biological 
payloads; 2). unique core shell, yolk shell, hollow structures for protection of the 
imaging agents; 3). rich surface chemistry for functionalization and stimuli-responsive 
releasing of therapeutic agents; 4). high biocompatibility/low toxicity; which is very 
promising as nanocarriers for theranostics applications.[6-16] With the aid of these 
nanocarriers, the performance of many imaging agents and therapeutic agents has been 
significantly improved.[6-10] However, current achievement is still as a proof of 
concept: 1). relatively few synthetic protocols can be used in-situ loading of biological 
payloads due to their harsh conditions; 2). there is still limited knowledge about the 
effects of chemophysical properties of the nanocarriers such as particle size, surface 
functionality, shape, structure on the toxicology and cell uptake; 3). labelling of 
nanocarriers for visualisation and tracking at ultra-low concentrations has been 
difficult; 4). less effective synthesis method for construction of nanocarriers with 
multicomponent and multifunctionality for realizing diagnosis and therapy 
simultaneously.[14-18] To address these key challenges, it is necessary to 1). develop 
innovative synthesis protocols for multicomponent nanocarriers; 2). develop 
innovative chemical approaches to label nanocarries for visualisation and tracking; 3). 
develop integrated nanotechnology platforms for diagnosis and therapy. 
1.2 Research objectives 
This thesis aims to develop an integrated multicomponent nanocomposites platform 
for effective diagnosis and therapy. A novel class of biocompatible nano-carriers with 
well-defined structures and surface properties will be developed for targeted and 
controlled drugs/genes delivery. The close correlation between particle morphologies 
and their cytotoxic effect will be studied by employing in vitro cell systems as well as 
in vivo studies with animal models. The mild wet chemistry synthesis method will be 
designed for in-situ immobilise biomolecules. This study will generate knowledge on 
the synthesis protocols for multicomponent nanocomposites, and give suggestions on 
how to design effective nanoparticles for biomedical applications. The specific 
objectives of this study are listed as follows: 
1. Synthesising multicomponent mesoporous silicas, carbons (magnetic mesoporous
silica nanocomposites, raspberry-like silica nanospheres, raspberry-like carbon
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spheres) with desired shape, surface functionality, particle size and porous structures, 
which can provide specific affinity surface and large cages for the loading and easy 
diffusion of biomolecules; 
2. Developing mild and greener synthesis methods for silicas or metal nanoparticles; 
3. Providing novel insights in understanding the effects of particle size, shape, porous 
structure and surface chemistry on the deposition, uptake, translocation, and toxicity 
of nanoparticles;  
4. Identifying emerging multicomponent nanocomposites platform on biomedical 
applications with mechanistic studies. 
 
1.3 Thesis organization 
This thesis consists of eight chapters, including introduction, literature review, results 
and discussions (five chapters), conclusions and perspectives for future studies.  
 
Chapter 1 ― Introduction ― gives a brief introduction to the background, 
encountered issues, and solutions in regard to multicomponent complex nanoparticles 
for biomedical applications. This chapter also includes the objectives of the research 
and structural organization of the thesis. 
 
Chapter 2 ― Literature review ― comprehensively summarizes the development of 
nanoparticles with multi-compartments, such as hierarchical porous structures, core-
shell, yolk-shell, Janus structured particles for efficient diagnosis and therapy 
applications. Promising future directions of this active research field are also 
highlighted. 
 
Chapter 3 ― Magnetic Fe3O4 and mesoporous silica core-shell nanospheres with 
tunable size and large void pore for cellular uptake. (Frontiers of Chemical Science 
and Engineering, 2014, 8, 114–122.). ― reports a facile method for fabrication of 
magnetic core and mesoporous silica shell nanocomposites with hierarchical pores on 
the shell. The obtained nanocomposites combined magnetization response and large 




Chapter 4 ― Inorganic-salts assisted self-assembly of Pluronic F127-organosilica 
into ordered mesostructures. (Journal of Nanoscience Nanotechnology 2016, 
16, 9173–9179.). ― develop a mild synthesis method and unravels the formation 
mechanism for mesoporous organosilicas with various mesostructures. The developed 
mild synthetic strategy provides the opportunity to in-situ load biomolecules into 
nanocarriers.  
 
Chapter 5 ― Less is more, greener microbial synthesis of silver nanoparticles. 
(Enzyme and Microbial Technology, 2014, 67, 53–58.). ― demonstrates that silver 
nanoparticles (AgNPs) can be synthesized in several types of microorganism culture 
broth without any specific living microbe involvement. The developed strategy 
dramatically simplifies the conventional microbial nano-synthesis process and thus 
provides a more eco-friendly way for nano-Ag preparation. 
 
Chapter 6 ― One-pot synthesis of raspberry-like mesoporous silica nanospheres. 
(Journal of Nanoscience Nanotechnology 2017, 17, 9173–9179.). ― reports a one-
pot synthesis method for raspberry-like mesoporous silica nanospheres with 2 nm 
hollow silica nanoparticles doped on the surface. A diverse library of multi-
compartment mesoporous silicas networks consist of mesoporous silica nanospheres 
connecting with mesoporous silica branches has also been synthesized through this 
method. The synthesis method would enable one to synthesize hierarchical 
mesoporous silicas with complex architecture and different pore environments for the 
potential application in nanomedicine. 
 
Chapter 7 ― Raspberry-like hollow carbon nanospheres with enhanced matrix-free 
peptide detection profiles. (Chemical Communications, 2016, 52, 1709–1712.). ― 
synthesize hollow colloidal carbon nanostructures with raspberry-like morphology. 
This facile method is highly reproducible and straightforward to synthesize uniform 
hollow colloidal carbon nanostructures with controllable surface properties and Janus 
particles. The as-prepared raspberry-like HCCNs display superior performance to 
smooth HCCNs in the LDI-MS detection of peptides, which has been ascribed to the 




Chapter 8 ― Conclusions and perspectives ― highlights the meaningful findings in 
this study and proposes suggestions for further research in the field. 
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Chapter 2. Literature review  
2.1 Introduction  
As a multidisciplinary of chemistry, material science, biotechnology, and biomedicine, 
nanobiotechnology has received burgeoning scientific and clinical attention in the past 
decade.1-11 One of these topics in nanobiotechnology is the development of 
multifunctional nanocarriers with hierarchical structures, which can integrate 
diagnostic and therapeutic functions into one nanoparticle for theranostic applications. 
To achieve this goal, diverse types of organic (e.g., polymer, micelles, liposomes, 
vesicles and dendrimers) or inorganic (e.g., silicas, carbons, graphene, metal oxides 
and semiconductors) nanocarriers have been developed for loading or encapsulating 
therapeutic agents and imaging agents. Among them, one particular class of 
nanocarriers namely mesoporous silica nanoparticles (MSNs), has attracted much 
attention for theranostic applications. 
     Since the discovery of mesoporous silica materials by Mobil scientists in 1992,12,13 
significant progress has been made toward the design and fabrication of mesoporous 
silicas with different structures, controlled morphologies and tailored properties. By 
using a soft templating or a hard templating approach, a range of MSNs including rods, 
tubes, plates, ellipsoids, spheres, cubes, raspberry-like, hollow, core-shell and yolk-
shell structures, and Janus particles have been produced in the laboratory. With a series 
of extraordinary features, such as large surface area, highly diversified structures, 
controlled porosity, chemical functionality, low toxicity and high biocompatibility, 
MSNs are very promising for biomedical applications including bioimaging, 
drug/gene delivery, tissue engineering, cancer therapy and in vitro diagnostics.1  
To further functionalize MSNs as a platform for biomedical applications, the 
development of multi-compartment mesoporous silica nanoparticles (MCMSNs) is 
crucial. MCMSNs offer great potential in theranostic applications because of their 
multi-functionality by the combination of therapeutic agents (e.g., anticancer drugs, 
DNA, small interfering RNA [siRNA], proteins, etc.) and imaging agents (e.g., 
quantum dots [QDs], upconversion particles [UCNPs], MRI contrast agents, etc.).  
They also have the possibility to selectively locate these functionalities onto different 
positions of the hierarchical structured particles by precisely controlling the surface 
chemistry. As summarized systematically in Figure 2.1, to date, MCMSNs with 
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various structures such as core-shell, yolk-shell, Janus, or raspberry-like particles have 
been synthesized by incorporating or encapsulating various imaging agents from 
organic dyes, QDs, UCNPs, MRI contrast agents, to CT contrast agents as a platform 
for biomedical diagnosis applications. Meanwhile, many different therapeutic agents 
including anticancer drugs, antiphlogistic drugs, antibacterial drugs, antihepatic 
fibrosis drugs, DNA, small interfering RNA [siRNA], proteins, etc. have been 
encapsulated and delivered by using MSNs as nanocarriers. Despite recent progress, 
the multifunctionalization of MSNs to fabricate MCMSNs and realize diagnosis and 
therapy simultaneously is still a major challenge for materials scientists and chemists. 
The nomenclature adopted in this review as demonstrated in Figure 1 is primarily 
including core-shell structured mesoporous silica nanoparticles (cs-MSNs), yolk-shell 
structured mesoporous silica nanoparticles (ys-MSNs), and Janus structured 
mesoporous silica nanoparticles (j-MSNs). The combination of the cs-MSNs, ys-
MSNs, and j-MSNs for generating more complex structured MSNs with multi-pods 
are also reported in the literatures for a special biomedical application. 
So far, there are many excellent reviews available on the synthesis and biomedical 
applications of mesoporous silicas.1-3,14-28 However, these reviews have focused  on 
the synthesis of spherical mesoporous silicas particles,22,25,29 hollow structures,2,24 
core-shell structures,18 dendritic structures,27 surface functionalization and 
organosilicas,20 and a specific application such as drug delivery and gene 
transfection,15,23,26,28 in vivo bio-safety evaluations,16 and cancer therapy.3,14 Indeed, 
an up-to-date  review on the protocols for the construction of multi-compartment 
mesoporous silica nanoparticles with multiple properties and tunable functionalities 
for theranostic applications is timely for guiding scientists to design MCMSNs for 
specific  biomedical applications. In this review, however, the focus is placed on recent 
research progress in the systematic synthesis methodologies of multi-compartment 
mesoporous silica nanoparticles and their biomedical applications. This review is 
organised as follows: after a brief overview of synthesis of MSNs, the first part briefly 
covers various general methods developed for the synthesis of MCMSNs. By 
discussing some representative MCMSNs as examples, we present a summary of the 
key synthesis strategies for controlling the particle size, geometry, structure and 
functionalisation. Core-shell, yolk-shell, raspberry-like and Janus structured 
mesoporous silica particles, will be then discussed. The following section is devoted 
to review the potential biomedical applications. The chemophysical properties of 
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MCMSNs (eg. particle structure, particle size, pore size and geometry, surface 
property, and particle shape) effects on the in vitro cellular uptake, intracellular 
translocation and cytotoxicity, in vivo biodistribution, biodegradation, excretion, and 
toxicity will be discussed. We will closely examine the research on the combination 
loading of imaging agents and therapeutic agents into one particle to generate 
multifunctional MSNs based platforms for theranostic applications. Finally, the state 




Figure 2.1 Schematic illustration for construction of multi-compartment mesoporous 
silica nanoparticles (MCMSNs) as a platform for diagnosis and therapy applications.   
 
2.2 Categories and synthesis methods of multi-compartment mesoporous silica 
nanoparticles (MSNs)  
After the early reports on mesoporous silica nanoparticles by the groups of Cai30 and 
Mann,31 independently, the term MSNs has been well popularized by several groups 
including Bein,32-36 Kuroda,37-44 Haynes,45-48 Huo,49-53 Hyeon,3,54,55 Lin,15,28,56,57 
Mou,58-60 Shi,2,16,61-64 Tang,17,21 Wiesner,65-67 Vallet-Regi,19,68,69 Zhao70-75 and 
Zink1,14,22,76,77 et al. Over the past decade, several research groups have reported 
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diverse synthesis protocols for MSNs as illustrated in Figure 2.2 with various pore 
sizes and pore structures,  different morphologies including rods, cubes, plates, 
ellipsoid, and spheres, also  the more complex structures derived from the above 
mentioned morphologies such as core-shell, yolk-shell and hollow structures, and 
Janus particles. The dominant synthetic methods developed for MSNs are the soft 
templating method and its derivative methods. By tuning the synthesis parameters such 
as pH value of the synthesis solution, the concentration of reagents and the template 
categories, a series of particles with different morphologies, pore size and particle size 
can be achieved.  
As summarized in Table 2.1, Yu et al. first reported the synthesis of rod-like 
mesoporous SBA-15 1~2 µm in length through an inorganic salts assisted soft-
templating method.78 Later, Sayari and coworkers demonstrated 1.5 × 0.4 µm 
mesoporous SBA-15 straight rods can be prepared by adopting the synthesis method 
of SBA-15 but under static conditions without using salts.79 Recently, Jang and 
coworkers modified the Stöber method to prepare MCM-41 type mesoporous silica 
rod-like nanoparticles (MSRNs) with different aspect ratios in a gram-scale by 
controlling the water to ethanol ratio.80 As a special type of MSRNs, mesoporous silica 
helical rods nanoparticles (MSHRNs) have also been widely investigated.81-84 As an 
example, by using perfluorooctanoic acid (PFOA) and cetyltrimethylammonium 
bromide (CTAB) as a dual template, Yang et al. reported the synthesis of MSHRNs 
and proposed an interfacial interaction mechanism.82 In comparison with mesoporous 
silica rods, it is very difficult to synthesize mesoporous silica cube-like nanoparticles 
(MSCNs) using a soft-templating method. In most cases, hard templates such as 
hematite,85-87 calcium carbonate,88 and Co3[Co(CN)6]289 have been employed for the 
preparation of hollow mesoporous silica cubes through an efficient mesoporous silica 
coating and template etching process. Alternatively, Stein and coworkers reported the 
fabrication of MSCNs through disassembling of ordered hierarchically porous 
structures derived from etching of the dense packing of colloidal crystal 
poly(methylmethacrylate) (PMMA) spheres. However, it is a challenge to control the 
purity of the resultant mesoporous silica cubes.90 Soft-templating method was 
developed by Han et al. for MSNs, which were synthesized by using dual surfactants 
F127 and FC-4 in acidic conditions, part of the resultant IBN-1  also shows cubes 
morphology.91 Compared to MSCNs, mesoporous silica ellipsoid-like nanoparticles 
(MSENs) are more popular and can be prepared using a soft-templating method.34,92-
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95 Both MSENs with mesoporous channels oriented along the long axis and the short 
axis have been synthesized by using a water/oil emulsion templating method. By using 
an emulsion template formed from dibenzyl ether in water, Hao et al. reported the 
synthesis of 200 × 100 nm MSENs with 3.3 nm meso-channels running along the short 
axis.94 
 
Figure 2.2 Schematic illustration for construction of MSNs with various pore sizes 
and pore structures, different morphologies from single-compartment to multi-
compartment.  
 
Among all MSNs, mesoporous silica spherical-like nanoparticles (MSSNs) are the 
most intensively investigated due to the well-developed methods and wide 
applications. There are many mature methods for preparing MSSNs with a particle 
size range from 20 nm to a few hundred nanometers, including hard and soft-
templating, aerosol-assisted self-assembly, microemulsion templating, Stöber 
synthesis, and self-etching method. These synthesis methods have also been widely 
applied to prepare hollow mesoporous silica nanoparticles (h-MSNs), which will be 
discussed in the ys-MSNs section.  
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Table 2.1 Summary of the synthesis method for different mesoporous silica 
nanoparticles (MSNs) with various pore sizes and different morphologies. 



























































































Figure 2.3 Gallery of MSSNs: Typical TEM images of various mesoporous silica 
spherical-like nanoparticles (MSSNs) synthesized by different methods, A-D, MSSNs 
with different pore size;45,74,109,126 E, F, MSSNs with different porous structures;51,65 
G-I Dendritic MSSNs with different particle size.109,118,127 
 
    By utilizing water and ethanol as solvents, ammonia solution as the catalyst and a 
cationic surfactant such as CTAB as the soft-template, the modified Stöber method is  
extended to synthesize sub-micrometer MSSNs.96 Yano and coworkers have widely 
investigated the modified Stöber method for the synthesis of MSSNs with radially 
aligned mesopores.97,98 They also proposed the formation mechanism and explained 
why monodispersed MSSNs can be prepared by a Stöber method.99-102 One of the most 
popular methods which has been widely adopted in the MSSNs and core-shell 
structured MSSNs preparation was developed by Cai and his colleagues by using a 
dilute surfactant solution.30 Later, by varying the initial silicate/surfactant 
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concentration, Nooney et al.103 further extended the above mentioned method to 
synthesize MSSN with particle size range from 65 to 740 nm. Since then, the research 
in this area has focused on controlling the particle size, pore size and dispersity of the 
MSSNs. The typical TEM images of MSSNs with different particle size, pore size, 
porous structures are summarized in Figure 2.3. Mou and co-workers synthesized 
MSSNs with tailoring particle size from 30 to 280 nm by tuning the pH of the reaction 
medium.60 Dialysis process has been used for preparation of MSSNs with particle sizes 
below 50 nm.38-40,42,43 Moreover, cubic Ia3d or Pm3n symmetry mesoporous 
structured MSSNs,65,104,105 MSSNs with worm-like pores,51,106 MSSNs with larger 
pore size91,107-111 have also been synthesized either in basic or acidic conditions by 
employing different surfactants as  templates.  Using block copolymer polystyrene-b-
poly (acrylic acid) (PS-b-PAA) and CTAB as dual templates, Niu et al.109 reported the 
synthesis of MSSNs with interconnected open mesoporous channels larger than 12 nm. 
As a special type of MSSNs, dendritic MSSNs shown in Figure 3G-I with open large 
pore channels are of particular interest due to the highly accessible internal surface 
area for biomedical applications.27,74,118,128,129 The used synthesis methods include 
microemulsion, biphase stratification and hard templating method. As Du and Qiao 
recently have provided comprehensive reviews on the synthesis and applications of 
dendritic MSSNs,27 the current review focuses mainly on the synthesis and biomedical 
applications of complex MSNs including core-shell structured mesoporous silica 
nanoparticles (cs-MSNs), yolk-shell structured mesoporous silica nanoparticles (ys-
MSNs), and Janus structured mesoporous silica nanoparticles (j-MSNs). In principle, 
as shown in Figure 2.2, the hollow, core-shell and yolk-shell structures with diverse 
morphologies and chemical compositions can be designed and synthesized by 
combining and modifying the schematic structures shown in Table 2.1. Only two 
typical examples of Janus structured silicas are illustrated in Figure 2.2, one represents 
a Janus particle with different properties on two faces, the second category is the 
combination of two or more different MSNs. In principle, more than 100 kinds of Janus 
structured MSNs can be created by the integration of the single and multi-compartment 
MSNs shown in Figure 2.2. 
2.2.1 Core-shell structured mesoporous silica micro/nanoparticles 
The combination of the diverse inorganic nanocrystals in the core with the unique 
properties of mesoporous shells creates the emergence of core-shell and yolk-shell 
structured mesoporous silica micro/nanoparticles as the first class of functional MSNs 
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as discussed in several excellent review papers.18,75,130-133 However, in this section, we 
will begin by simply summarizing the most popular self-assembly coating methods. 
Separated MSNs and functional nanoparticles are normally formed rather than the 
core-shell composites, because of the lack of interaction between two particles. 
Therefore, the surface modification or the secondary growth is usually necessary to 
fabricate cs-MSNs.  
Similar to the synthesis of MSSNs, the modified Stöber method has been widely 
adopted for coating and generating mesoporous silica shells. A cationic surfactant such 
as CTAB is commonly employed, which not only acts as a template for mesopores, 
but also as an agent to alter the surface charge of the core materials using “growth 
seeds”. Ordinarily, to make better use of MSNs, mesoporous silicas have been used 
either as the core or shell materials. By selecting MSNs as cores, polymer such as 
polyethyleneimine,134-136 poly(ethylene glycol) (PEG),137,138 poly-L-lysine (PLL),110 
poly(N-isopropylacrylamide) (PNIPAM),139,140 poly(methacrylic acid-co-vinyl 
triethoxylsilane) (PMV),141 poly(N-vinylcaprolactam-co-methacrylic acid) (P-(VCL-
s-s-MAA)),142 polymer copolymer−lipid,33,35,143 or layered double hydroxides 
(LDHs),144 and metal organic frameworks (MOFs),145 have been coated as shells for 
the applications of drug and gene delivery. In order to endow MSNs with unique 
optical, plasmonic, acoustic and magnetic properties for theranostics applications, the 
core particles used so far for spherical cs-MSNs with mesoporous silica shells 
including silica,64,74,146-153 MOFs,154 gold,155-167 platinum,168,169 silver,72,170-172 
UPCNs,173-190 QDs,128,163,191 photoluminescent nanodiamonds (NDs),192,193 graphitic 
carbon,63,194 magnetic nanoparticles (M NPs),55,77,145,195-225 manganese oxide 
nanoparticles (MnO NPs),226-228 Gd2O3:Eu nanocrystals,229-231 AgS2 nanocrystals,232 
copper chalcogenide (Cu9S5) nanocrystals,233 and Cu2-xSe nanoparticles.234  
Some typical TEM images of these cs-MSNs are summarized in Figure 2.4. The 
position of the core can be either eccentric or concentric, radial mesoporous silica 
shells can also be realized. It is also of vital importance to coat mesoporous silica shells 
to reduce the toxicity of the core functional nanoparticles and to avoid their 
aggregation during the therapy process. By employing the core materials with different 
morphologies, the self-assembly coating method has been extended to prepare cs-






Figure 2.4 Gallery of cs-MSNs: A Schematic illustration and B-L typical TEM images 
of cs-MSNs with various core and different pore size of mesoporous silica shells. B, 
TEM image and C, 3D reconstructions of Au@meso-SiO2;155 D, TEM image of 
Pt@meso-SiO2;168 E, TEM image of Ag@meso-SiO2;170 F, TEM image of 
UPCNs@meso-SiO2;189 G, TEM image of Fe3O4@meso-SiO2;54 H, TEM image of 
MnO@meso-SiO2;226 I, TEM image of Gd2O3@meso-SiO2;231 J, TEM image of 
Ag2S@meso-SiO2;232 K, TEM image of Cu9S5@meso-SiO2;233 L, TEM image of 
Fe3O4@dendritic meso-SiO2.225 
 
Coating of gold NPs, UPCNs, and magnetic Fe3O4 NPs with meso-silica shell is the 
most popular process for the development of biomaterials with plasmonic, optical, 
acoustic and magnetic properties, respectively for diagnosis and integrate treatments 
of chemotherapy, photodynamic therapy (PDT), and photothermal therapy (PTT). To 
date, due to their tunable localized surface plasmon resonance (LSPR) for adsorbing 
near infrared (NIR) radiation, many attempts have been carried out to prepare 
Au@meso-SiO2 with a gold core and mesoporous silica shell for both cancer cell 
imaging and PTT application.155-160,167,236-241 Additionally, UCNPs@meso-SiO2 have 
been widely synthesized and applied in the field of bioimaging due to their unique 
ability of upconverting low-energy NIR light to high-energy ultraviolet (UV), visible 
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(vis) and NIR light.174,175,178,180,181,189,221  For magnetic resonance imaging (MRI) and 
magnetic bioseparation applications, significant effort has also been devoted to prepare 
magnetic Fe3O4@meso-SiO2 with controlled particle size.18,109,131,133,197,198,207,214,216-
219,223,225,242-245 Furthermore, multifunctional cs-MSNs with multiple cores or shells 
such as magnetic, UPCNs, plasmonic NPs, fluorescent dyes have been developed for 
multimodal imaging or theranostics.174,182,186,189,195,200-205,209,212,246,247 For example, 
Chen et al. reported the synthesis of ellipsoidal Fe3O4@SiO2@mesoSiO2 coated with 
multi-layers of polyelectrolyte (PAH)/QDs to combine the merits of functional 
particles.200 In addition, Sun et al. successfully synthesized Gd3+ ion doped 
UCNPs@meso-SiO2-Ln(dbm)4 (Ln = Eu, Sm, Er, Nd, Yb) with the combination of 
magnetic resonance imaging (MRI), upconversion, and downconversion luminescence 
imaging into one particle.186 Therefore, multifunctionlization of cs-MSNs is crucial 
for their further applications in theranostics. 
 
 
Figure 2.5 (A), (B) TEM images and (C) N2 adsorption-desorption isotherms and BJH 
pore diameter distribution curve at adsorption branch (inset) of DMSSNs64, (D), (E), 
TEM images of Mn- DMSSNs; (F) Scanning TEM image with high angle annular dark 
field (STEM-HAADF) and corresponding EDS elemental mapping images and 
EDS.242 
 
    In addition, great attention and effort have been devoted to the fabrication of dual 
mesoporous cs-MSNs (DMSSNs) with different pore size and structures with core and 
shells.64,71,74,150-152,154,248 As shown in Figure 2.5A-C, core–shell structured DMSSNs 
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with 2 nm mesopores in the shell and 14 nm mesopores in the core were successfully 
synthesized from Shi’s group by utilizing an amphiphilic block copolymer 
(polystyrene-b-poly(acrylic acid), PS-b-PAA) and CTAB as dual templates. They 
further extended the method to encapsulate ultrasmall manganese oxide nanoclusters 
and magnetic Fe3O4 into the pore channels of DMSSs to generate Mn@DMSSNs (Figs. 
2.5D-F)242 and Fe3O4@DMSSNs,248 respectively. Moreover, Yang and coworkers 
reported the one-pot synthesis of cs-MSSNs with dual oriented mesochannels and 
controlled pore size (3.0 to 7.3 nm) by using CTAB as a template with the aid of 1,3,5-
trimethylbenzene (TMB) in a basic medium.152 Design and fabrication of cs-MSSNs 
with triple, and more hierarchical porous structure and size is expected in the future 
studies. 
2.2.2 Yolk-shell structured mesoporous silica micro/nanoparticles  
As a sub-class of core-shell particles, the yolk-shell nanoparticles (YSNs) or so called 
'nano-rattles' with a distinctive core@void@shell structure, in principle, open a new 
platform for theranostic applications. The construction and applications of YSNs has 
already been well reviewed by the groups of Fromm,249 Lee,250 Lu,29,251 Shi,2 Song,252 
FQ Tang,17 ZY Tang,253 Yang,254 Zeng,255 Zheng,256 and recently by Liu and 
Priestley,130 Purbia and Paria,257 Zhang and Yin et al.258 Specifically, the synthesis of 
yolk-shell structured mesoporous silica nanoparticles (ys-MSNs) can be started from 
cs-MSNs by selective etching the core or shell, or etching the middle sacrifice layer. 
Different etching agents including HF,259,260 KCN,261 Na2CO3,235,260,262 
ammonia,263,264 H2SO4 and Na2SO4265 have been chosen to selectively etch the inner 
or middle sacrificial silica layer partially or completely; whereas the porous silica shell 
remained intact due to the structural differences in core and shell. Alternatively, it can 
be started from h-MSNs through the “ship-in-a-bottle” strategy.266 For example, Chen 
and co-workers266 have adapted this approach to synthesize UPCNs@meso-SiO2 
YSNs by encapsulating a trifluoroacetate precursor into h-MSNs and following a 
calcination step. A one-pot soft templating method has also been developed for the 
preparation of ys-MSNs.267-270 Early work by Liu et al. reported the synthesis of ys-
MSNs either with a mesoporous silica shell268 or PMO shell269 by a soft-templating 
method adapting FC4 and F127 as dual templates. Organosilane assisted etching 
method was also developed by Yang et al. for construction of ys-MSNs with PMO 
shell.271,272 Applying the similar synthesis protocols, Teng et al. reported the triple-
hybridized PMO YSNs with ethane, thioether-, and benzene-bridged moieties 
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simultaneously incorporated. It worth to noting nano-matryoshkas with multiple layers 
of yolk-shell can be obtained by either selective etching method or soft-templating 
method.263,267 Similar to its cs-MSNs counterparts, to date, ys-MSNs with different 
cores such as silica spheres (SSs),260,265,267-269,273,274 MSSNs,268,272,275,276 
Au,53,165,240,263,264,268,274,277,278 ZnS,278 Co3O4,278 TiO2,278 Fe2O3,150,279 Fe NPs,280 
UPCNs,173,266,281-283 magnetic Fe3O4,235,268,271,277,284-292 Ag/AgBr,293 Gd2O3:Eu294, 
BaFeO NPs,295 have been prepared accordingly, and their corresponding TEM images 
are shown in Figure 2.6. By selecting core materials or h-MSNs with different 
morphologies, many yolk shell structured ellipsoidal particles,150,235,280,282 
nanoplates,296 rod-like particles159,166 have been fabricated through the above 
mentioned methods. In addition, ys-MSNs with polymer shells were synthesized by 
coating a sheddable thermo/pH-sensitive P-(VCL-s-s-MAA) polymer onto a 
carboxylic acid modified MSNs (MSN-COOH).142  
 
 
Figure 2.6 Gallery of ys-MSNs: A Schematic illustration and B-I typical TEM images 
of ys-MSNs with various core. B, silica spheres (SSs);268 C, D, mesoporous silica 





    Aiming at theranostics applications, similar to cs-MSNs, many research groups have  
focused  on the design and synthesis of multifunctional ys-MSNs.170,276,281,282,285,294,297 
Lv et al.282 demonstrated the synthesis of yolk-shell structured GdOF:Ln@mesoSiO2 
(Ln = 10%Yb/1%Er/4%Mn) with strong up-conversion luminescent (UCL) GdOF:Ln 
as the cores and mesoporous silica shells (Fig. 2.7). Then, PDT agent ZnPc and carbon 
dots (CDs) have been selectively located onto the core and outside the shell, 
respectively (Figs. 6a-c). The resultant multifunctional ellipsoidal particles with UCL 
imaging, MRI, and computed tomography (CT) imaging properties are excellent 
candidates for multimodal imaging guided multiple therapies. In addition, 
multifunctional ys-MSNs were simultaneously functionalized with photosensitizer 
Chlorin e6 (Ce6), photothermal agent CDs, and imaging agent Gd (III) ions, and a 
stimuli-responsive polymer (P(NIPAm-co-MAA)) have been coated on the out-layer 
for the integration of chemotherapy, PDT and PTT theranostic systems.276 
 
 
Figure 2.7 (a and b) TEM images with different magnification, (c) morphology sketch, 
(d)STEM image, (e) EDS, and(F) the cross-sectional compositional line profiles and 
elemental mapping images of GdOF:Ln@mSiO2-ZnPC-CDs.282 
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2.2.3 Multipodal and Janus structured mesoporous silica micro/nanoparticles  
Janus nanoparticles with asymmetric chemistry and structures in its two faces, have 
emerged as attractive nanomaterials. Owing to its unique structure in 
compartmentalizing multiple building blocks, Janus nanoparticles with controlled 
geometry and multiple compartments have shown many interesting properties in 
various potential applications including drug delivery, optical probes, self-propelled 
motors and solid surfactants.298 To date, various methods have been reported to prepare 
Janus nanoparticles including emulsion, microfluidics, self-assembly assembly and 
one-step synthesis. It is well recognized that the properties of the obtained Janus 
particle strongly depend on their morphology and compositions.  
     
 
Figure 2.8 TEM images and schematic illustration of j-MSNs with multi-compartment. 
(A) one arm, (B) two arms, (C) three arms, (D) four arms67 and (E) five arms.49,299 
 
    In 2013, Wiesner’s group reported a one-pot synthesis method to obtain Janus 
structured mesoporous silica micro/nanoparticles containing both a cubic mesoporous 
structured core and hexagonal mesoporous structured branches within one particle.67 
As shown in Figure 2.8, the advantage of this method is that the amount of mesoporous 
cylindrical branches can be controlled with variations in ethyl acetate concentration 
[EtOAc] in the synthesis mixture. The key step in this method is to decrease the pH 
and change in the charge state of (3-aminopropyl)triethoxysilane (APTES) during the 
hydrolysis of EtOAc. Later, using NaOH as a catalyst and CTAB as a template, 
Croissant et al. also reported the synthesis of multipodal PMO j-MSNs with 
phenylene-PMO cores and ethenylene-PMO pods.299,300 While phenylene-PMO 
nanospheres and ethenylene-PMO nanorods were obtained by using their sole 
corresponding precursor, multipodal PMO j-MSNs can be generated by the subsequent 
addition of the ethenylene precursor into a solution of freshly-prepared phenylene-
PMO nanospheres. Through a two-step sprout-like growth method, Huo and co-
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workers reported the j-MSNs consist of a PMO core and up to three branches with 
mesoporous pure silica nanorods growing out of the cubic core vertices.49 Ujiie et al. 
synthesized less than 100 nm j-MSNs with MSNs asymmetrically capped with non-
porous phenylsilsesquioxane by the post modification of MSNs with 
phenyltriethoxysilane.37 
     
 
Figure 2.9 (A) SEM images of the obtained UCNP@SiO2@mSiO2&PMO Janus 
nanocomposites. (B) The statistic results of the relative positions between the 
core@shell@shell UCNP@SiO2@mSiO2 nanosphere domain and PMO single-crystal 
nanocube domain of Janus nanoparticles: the nanosphere attached on the vertex, edge, 
or face of the nanocube. (C) The SAXS pattern of the Janus mesoporous 
nanocomposites (inset: the theoretical and experimental d-spacing values of different 
planes obtained from the cell parameter and SAXS pattern). (D−F) The TEM images 
along with the corresponding fast Fourier transform of the Janus nanocomposite along 
[001] (D), [111] (E), and [210] (F) zone axis.283 
 
    For practical applications, significant efforts have been made to develop j-MSNs 
that simultaneously display multiple functions. For instance, as shown in Figure 2.9, 
Zhao and co-workers reported an anisotropic growth-induced approach to synthesize 
both Janus UCNP@SiO2@mSiO2&PMO and UCNP@SiO2@mSiO2@PMO with an 
up-conversion core and MSNs shell onto ethenylene-PMO cubic pods by varying the 
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H2O to ethanol ratio in the synthesis mixture.283 The formation of j-MSNs in solution 
involves nucleation of PMO onto the UCNP@SiO2@mSiO2 core followed by 
anisotropic island growth. By using NH3·H2O as both a basic catalyst and an etching 
agent, a one-pot asymmetrical/symmetrical coating method has also been developed 
to prepare j-MSNs with gold an PMO, or yolk–shell Au@PMO nanostructures with 
different morphologies.53 Furthermore, j-MSNs with magnetic Fe3O4,301 Au,241,302-305 
Pt,306,307 Ag,308 and Ni,309,310 heads and mesoporous silica body have been prepared 
through the asymmetrical coating method and electron beam deposition. Huo and co-
workers also found that the length of growth of the mesoporous silica was able to be 
controlled by increasing and decreasing the ratio of TEOS to the head.241,283,301 
Noteworthy is that various j-MSNs nanomotors were synthesized by Sanchez and co-
workers306,307,309-311, and used for biomedical applications which will be discussed in 
the following section. 
    As a special type of j-MSNs, raspberry-like mesoporous silica nanospheres (RMSNs) 
with many small particles or pods decorating the surface of one large particle are of 
particular interest owing to their hierarchical structures and tunable surface 
properties.132,312-314 Scherman and co-workers reported the synthesis of raspberry-like 
mesoporous hollow silica nanospheres (RHMSNs) with paramagnetic Fe3O4 
nanoparticles decorating  the shell by utilizing host–guest complexation of cucurbituril 
(CB).313 By using a microfluidic approach, Zhao et al. demonstrated the synthesis of 
monodisperse raspberry-like hierarchical silica particles.315 The one-pot synthesis of 
raspberry-like hierarchical siliceous hollow spheres has also been reported through a 
vesicle or emulsion template.316,317 RHMSNs were also successfully synthesized by 
using  carbon spheres as a hard template and CTAB as a soft template, respectively.318 
 
2.3 Biomedical applications 
MSNs have emerged as an excellent candidates for theranostic applications owing to 
their stable structure, tunable pore size, large surface area and well-defined surface. 
Recently, many kinds of MSNs with multi-components or multi-compartments have 
been successfully synthesized and adopted for biomedical application purposes due to 
their advantageous structural properties, such as hierarchical structures, selective 
functionalization sites, and colloidal stability. So far, these MSNs have been developed 
for targeted drug/gene/protein delivery, bioimaging for diagnosis, tissue engineering, 
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cancer therapy, or the combination of diagnosis and therapy for theranostic 
applications. In this section, we will first discuss the stimuli-responsive drug delivery 
systems (DDS)319 and chemotherapy by loading drugs/gene into multi-component 
MSNs and surface functionalization of stimuli-responsive chemicals. The enhanced 
permeability and retention (EPR) effect can be improved to a certain level by adapting 
this strategy. Then we will introduce the bioimaging applications of MSNs with an 
emphasis on dual and multiple imaging application for disease accurate diagnosis. 
Phototherapies including photothermal (PTT) and photodynamic therapy (PDT) will 
be then discussed both for in vitro and in vivo applications. Recognizing that the 
theranostics using MSNs could offer a new approach to the treatment of degenerative 
diseases including cancer, the multiple components MSNs with bioimaging agents, 
tumor-targeting moieties, anticancer drugs, or siRNA, phototherapy agents for 
multimodal imaging, and dual therapy will be envisioned and discussed. The 
integration of treatments with chemotherapy, PDT, and PTT, in a single MSNs based 
nanoplatform is discussed for the potential in achieving super additive antitumor 
efficacy. 
2.3.1 Stimuli-responsive drug/gene delivery and chemotherapy 
Functionalization of MSNs with stimuli-responsive materials is emerging as a 
platform for “smart” stimuli-responsive drug delivery systems (DDSs) in order to 
improve the treatment efficacy and reduce the side effects of drugs during 
chemotherapy.1-3,14,16,23,235 Meanwhile, molecular and supramolecular nanovalves 
functionalized MSNs so called mechanized MSNs have attracted substantial attention 
and widely used in controlled cargo/drug release. In the past decade, a library of 
stimuli-responsive MSNs vehicles has been fabricated for the controlled release of 
guests in response to external stimulus including, temperature,140,143,176 
pH,141,143,176,177,187,195,202,265,308,320-330 light,35,158,167,183,188,198,237,276,281,331-333 
enzyme,215,304,334 biomolecule,137,142,175,335 redox,322,336 competitive binding337 and 
oscillating magnetic field.138,309,321 For example, the polymer P(NIPAm-co-
MAA)176,276 has been widely used for thermal responsive controlled release; dibenzo-
crown ethers,321 polyethylene-imine (PEI),  cyclodextrins (CDs),323 acid-
decomposable ZnO quantum dots177 modified MSNs have been synthesized for pH-
responsive controlled release; light-responsive azobenzene derivatives,198 
protoporphyrin IX (PpIX),35 sulfonatocalix[4]arene (SC[4]A) supramolecular,237 and 
gold NPs,332 were used to functionalize MSNs for visible light triggering release of 
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guest molecules. Lee and co-workers described the development of a polypeptide-
wrapped UCNP@MSNs as an adenosine triphosphate (ATP) biomolecules-responsive 
DDS for drug release (Fig. 2.10A).175 Fe3O4337 nanoparticles capped or disulfide-
based215,336 MSNs have been developed for redox-responsive controlled release. The 
controlled release processes are summarized in Figure 2.10 for different stimuli-
responsive MSNs systems. With the concept of a nanovalve-gatekeeper system of 
MSNs, Leung and co-workers synthesized MCMSNs with superparamagnetic iron 
oxide (SPIO) core, mesoporous silica shell decorated with a series of crown ether 
macrocycles for controlled release with ultrasound waves.321 It indicated that the 
crown ether-based nanovalves could be used to block Cs+ and Na+ ions for different 
modes of drug loading and release. The release profiles of DOX molecules were 
enhanced and triggered by ultrasound. In addition, dual responsive MSNs nanocarriers 
system with multiple functions, such as thermal and pH,143,176,338 glucose and 
pH,161,207,322 light and pH,339,340 thermal and redox,341 pH and redox,342,343 have been 
also investigated for controlled DDSs. Qiu et al.207 designed and synthesized core shell 
structured Fe3O4@MSNs@b-CDs for pH and sugar dual-responsive controlled 
release. Wu et al.143 reported a pH- and thermo-dual-stimuli-responsive MSNs 
nanocarrier, which have potential applications in clinical anticancer drug. Wang and 
co-workers342 reported dual responsive MSNs with an acid-dissolvable magnetic core 
and a redox-degradable poly(methylacrylic acid-co-N,N-bis(acryloyl)cystamine) 
(P(MAA-Cy)) shell, and the release of drug could be controlled by the  pH value and 
redox-agents. 
    With the development of stimuli-responsive controlled release MSNs system, 
ultilization of these MSNs including core-shell, yolk-shell structure and Janus particles 
for chemotherapy has been investigated. Hydrophobic antitumor drug (docetaxel, 
DOC) was loaded into ys-MSNs for in vitro and in vivo liver cancer therapy. Efficient 
cellular internalization was achieved as fluorescein isothiocyanate (FITC)-labeled ys-
MSNs monitored by fluorescence microscopy. The resulting ys-MSNs could 
successfully penetrate the plasma membrane of Hep-G2 cells and translocate into the 
cytoplasm with high efficiency. Moreover, the DOC-loaded ys-MSNs showed greater 
antitumor activity with about a 15% enhanced tumor inhibition rate compared to 
taxotere on the marine hepatocarcinoma 22 subcutaneous model.344 The photostimuli-
responsive ys-MSNs with an upconversion nanocrystal NaYF4:Tm3+,Yb3+–NaLuF4 
core and mesoporous silica shell have been used for the loading of aphototrigger-
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conjugated prodrug (combined anticancer drug chlorambucil and phototrigger agent 
amino-coumarin).281 These ys-MSNs possess the advantages of a high drug-loading 
capacity, zero premature release in nontargeted tissue, and sensitivity to NIR light with 
a wavelength that has a large penetration depth in tissue. 
 
Figure 2.10 Schematic illustration of stimuli-responsive controlled release process of 
cargo molecules. A. Light-responsive;175 B. pH-responsive;176 C. Redox-
responsive.215 
 
As shown in Figure 2.11a-e, Li and co-workers demonstrated that Janus Ag-MSNs 
can be selectively endowed with the surface plasmon resonance (SPR) and 
mesoporous properties. The Janus Ag-MSNs have been used as an effective drug 
delivery system for easy endocytosis, pH-responsive drug release and simultaneous 
SERS imaging (Fig. 2.11f-h). By adapting a similar concept, multifunctional Janus 
particles containing MSNs and gold have been developed.305 The fluorescence 
resonance energy transfer (FRET) pair and 6-mercaptopurine (6MP) either by pH or 
redox responsive bonds can be selectively functionalized onto the MSNs and gold, 
respectively. The Janus structured carriers have the potential for the real-time study of 
intelligent multi-drug delivery and release, as well as cellular responses to drug 
treatment. Villalonga et al.304 also reported the Janus MSNs and gold containing MSNs 
part capped with a pH-responsive gate, whereas the gold surface was functionalized 
with the enzyme urease. Janus-type integrated nanoarchitecture opens new routes for 
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the development of novel biologically inspired smart nanomachines for drug delivery 
and sensing applications. The future development of design multifunctional MSNs for 
targeted delivery can be envisioned. 
 
Figure 2.11 Synthesis and biomedical application of Janus Ag-MSN composites. (a) 
Schematic diagram of the fabrication procedure for the DOX-loaded Ag-MSNs and 
application for SERS imaging and pH-sensitive drug delivery in cancer therapy, (b) 
TEM images of Ag nanospheres, (c) SEM, (d) TEM images of Ag-MSNs, (e) 
Corresponding energy-dispersive X-ray spectroscopy (EDS) element mapping of Ag, 
Si, and O, respectively. (f) pH-dependent drug release profiles of Ag-MSNs-DOX. (g) 
Quantitative analysis of fluorescence intensity of DOX in free DOX or DOX-loaded 
Ag-MSNs treated HepG2 and HL-7702 cells for 3 h. These data represent three 
separate experiments and are presented as mean values ± SD *P < 0.05 versus control 
group, #P <0.05 versus DOX group. (h) CLSM images of HepG2 and HL-7702 cells 




2.3.2 Bioimaging  
The introduction of various imaging techniques including magnetic resonance imaging 
(MRI), computed tomography (CT),160,276 positron emission tomography (PET), 
upconversion luminescence (UCL) imaging,176 and optical imaging32,345 to the 
biomedical field has significantly improved the accuracy of medical diagnosis, 
especially for cancer. Semiconductor NPs128 and gold NPs are generally used as 
fluorescence probes for cell labeling in optical imaging. MRI is one of the most 
representative imaging techniques to offer high-resolution and superior-contrast 
images between the specific tissues and their surrounding tissues. Typically, Gd-based 
complexes276 or NPs229,230 and manganese oxide NPs226-228,346 have been used for T1-
weighted imaging, and iron oxide-based NPs77,202,204,235,239,290,347-349 have  been used 
for T2-weighted imaging.  
    MnO@mSiO2(Ir)@PEG with a manganese nanocrystal core and a functionalized 
mesoporous silica shell have been strategically designed for T1-weighted imaging.226 
Magnetic Fe3O4 NPs@mSiO2 have been used as the contrast agents for T2-weighted 
MRI. Yolk-shell structured Fe3O4@mSiO2 prepared through a ship-in-a-bottle method 
can achieve a 76.7% increase in its magnetic saturation value.350 Shi’s group reported 
the synthesis of multifunctional ellipsoidal MSNs by assembling CdTe quantum dots 
on the surface of Fe3O4@SiO2@mSiO2 via a novel layer-by-layer self-assembly 
technique.200 The resulting nanoellipsoids integrated the merits of magnetic 
manipulation, intracellular delivery, and MRI showed a relatively high r2 value 
(143/mM·s) as contrast agents for simultaneous MRI/fluorescence imaging. By the 
combination of two different modes of imaging (T1- and T2- weighted MR imaging), 
the development of dual-mode contrast agents (DMCAs) has been widely studied to 
improve the accuracy of decease diagnosis.242,294,351 Huang et al.351 combined the T1 
and T2-weighted imaging by the development of Gd3+-chelated Fe3O4@mSiO2, the 
resultant nanocomposites are endowed with enhanced transverse relaxation rates. 
Anker and co-workers also demonstrated  a yolk shell structured Gd-DTPA-
Fe@mSiO2 for dual MRI contrast imaging.280 For the high diagnostic requirements, a 
combination of multiple imaging probes into one single system for achieving multi-
modality imaging is expected.173,178,205,230,282,290 For instance, core-shell and yolk-shell 
structured Gd-UCNPs@mSiO2 have been employed for both MR and UCL 
imaging.178 As shown in Figure 2.12, Lin and co-workers synthesized yolk shell 
structured GdOF:Ln@mSiO2-ZnPc-DCs for multiple imaging (CT, MRI, UCL, 
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photothermal) applications.282 Similarly, Wang et al.177 also prepared 
UCNPs@mSiO2-ZnO as a nanotheranostic agent for the UCL/CT/MRI trimodality 
imaging. 
    Optical imaging techniques have also been widely used to monitor therapeutic 
release and distribution in real time. For example, a fluorescent dye like FITC has been 
combined with ys-MSNs via various methods such as absorption352, covalent 
amidation conjugation353, and in situ co-condensation 354. FITC-labeled ys-MSNs have 
been tracked through the whole process of endocytosis: from cellular membrane 
penetration, to endosomes, then escape to the cytosol, and finally expulsion by 
lysosomes. Interestingly, the new-generation clinically approved NIRF molecule 
indocyanine green (ICG), has been successfully attached to ys-MSNs in Tang’s 
group355. Since NIRF imaging has advantages such as high tissue penetration and low 
autofluorescence, it is applicable to noninvasive in vivo tracking for tumor-specific 
delivery and biodistribution in living animals. 
 
 
Figure 2.12 Schematic illustration for the synthesis of GdOF:Ln@mSiO2-ZnPc-CDs 
microcapsule and bio-application for multiple imaging and anti-tumor therapy.282 
 
2.3.3 Cancer therapy 
Ultrasound therapy,346 radiotherapy, chemotherapy,204,333 phototherapy,157,356 and 
magnetic hyperthermia-based therapies357 have been developed for cancer therapy. 
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Both chemotherapy and phototherapy have been widely applied for cancer therapy by 
using synthetic nanomaterials.8,10 Phototherapies including photothermal therapy 
(PTT) and photodynamic therapy (PDT) induced by light, preferably near-infrared 
(NIR) light with superior tissue penetration ability, can be used to selectively kill 
cancer cells under light irradiation. Generally, Au, Pt, and Ag can provide plasmonic 
properties and adsorb near infrared (NIR) radiation and have been proved to be 
effective PTT agents, though a mesoporous silica coating is necessary to reduce their 
cytotoxicity. Carbon nanomaterials also have been selected for PTT 
applications.63,71,194 PDT relies on the fact that local light excitation of photosensitizer 
(PS) will generate highly reactive oxygen species (ROS) for irreversibly damaging of 
malignant cells.184 Unlike PDT, PTT does not require oxygen, which is a hyperthermia 
(>41 °C) treatment of “cooking” tumorigenic cells, even hypoxic tissues. As illustrated 
in Figure 2.13A, Zhang et al.156 demonstrated Au@mSiO2 containing two-photon 
imaging (TPI) and hyperthermia agents can be used for cancer chemotherapy. Tang’s 
group showed that ys-MSNs can be used for cancer therapy by binding monoclonal 
CD73 or CD90 antibody-conjugated with mesenchymal stem cells (MSCs), the laden 
MSCs could actively find and migrate to solid tumor tissues to achieve the targeted 
drug delivery as shown in Figure 2.13B.  
    MSNs based integration of photothermal- and chemotherapies205,233,236 have been 
explored for combination therapy with reduced drug dosage and low laser power. Au 
NRs-capped magnetic Fe3O4@ mSiO2 nanoellipsoids have been used for 
chemotherapy, photo-thermotherapy, in vivo MR-, infrared thermal and optical 
imaging into one single system.205 As shown in Figure 2.13C, Luo et al.236 developed 
a core-shell structured GNR@mSiO2, in which a gold nanorod core and mesoporous 
silica shell have been used as the hyperthermal agent, and the reservoir of 
photosensitizer (Al(III)phthalocyanine chloride tetrasulfonic acid, AlPcS4), 
respectively. CD gatekeeper and tumor targeting ligand (lactobionic acid, LA) were 
further loaded onto these MSNs for controlled drug release and chemotherapy. Under 
laser irradiation, the produced destructive heat/ROS would trigger the remarkable 
tumor cell death. As confirmed by in vitro and in vivo studies, the nanocomposite 
exhibits an obvious near-infrared induced thermal effect, which significantly improves 
the PDT and chemotherapy efficiency, resulting in a superadditive therapeutic effect. 
Furthermore, ys-MSNs with gold–nanoshell has been used to combine hyperthermia 
therapy with chemotherapy for cancer treatment.358,359 In vitro experiments indicate 
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the combined hyperthermia and chemotherapy give a significantly enhanced cell-
killing effect toward HepG2 cells. All these results demonstrate the importance of the 
synergetic effect of combined photothermal therapy and chemotherapy. 
 
 
Figure 2.13 Schematic illustration A. Au@mSiO2 as a multifunctional theranostic 
platform for cancer treatment;156 B. ys-MSNs-DOX-anchored for tumor-tropic 
therapy;360 C. MMSGNR-AlPcS4 for tri-model high-performance tumor therapy.236 
 
 
Theranostic applications with a combination of multimodal imaging, photothermal 
therapy, and chemotherapy is expected to offer better therapy effects on cancer cells 
than individual therapy approaches in vitro and in vivo. As demonstrated in Figure 
2.14A, yolk shell structured Fe3O4@mSiO2 were developed as multifunctional 
systems for MRI/NIRF bimodal imaging probe for cancer diagnosis, and 
chemotherapy of cancer.290 Yang and coworkers276 designed a multifunctional ys-
MSNs with combined therapeutic effect (PDT/PTT/chemo) and dual imaging function 
(MRI/X-ray CT) (Fig. 2.14B). The ys-MSNs are surface modified by amino groups (-
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NH2) and then chelated with Gd-DTPA, doxorubicin (DOX) was chosen as the 
anticancer drug and encapsulated into the mesopores of ys-MSNs. Further 
modification with thermo/pH-sensitive polymer P(NIPAm-co-MAA)), which acted as 
a “gatekeeper” to control the release of the antidrug in ys-MSNs. Hu and co-workers 
report the anticancer drug of doxorubicin (DOX)-loaded core-shell nanostructured 
Cu9S5@mSiO2-PEG can effectively delivery DOX into cancer cells with a pH 
sensitive release profile for the combination of photothermal- and chemotherapies.233 
As discussed earlier, yolk shell structured GdOF:Ln@mSiO2-ZnPc-DCs prepared by 
Lin and co-workers have been well applied for both multiple imaging (CT, MRI, UCL, 
photothermal) and multiple therapies (PDT, PTT, and chemotherapy).282 Similarly, Shi 
and co-workers also demonstrated an multifunctional Gd-UCNPs@mSiO2 
nanotheranostic for MR/UCL bimodal imaging and synergetic chemo-/radio-
/photodynamic therapy.178   
 
 
Figure 2.14 Schematic illustration for A. PTX-loaded yolk shell structured 
Fe3O4@mSiO2 for tumor targeting, MRI, fluorescence imaging, and chemotherapy;290 







Recent years have witnessed a blossoming research in the development of 
multicomponent mesoporous silicas nanoparticles for theranostics applications. We 
began humbly by the design and development of MSNs and their surface 
functionalization, particle size, morphological and structural control. The potential 
applications of these MSNs are in biomedical diagnosis and therapy including 
drug/gene/protein delivery, bioimaging and cancer therapy. Despite the great 
opportunity of MSNs for theranostic applications, the research is still in its infancy, 
and there are considerable challenges for the actual use of MSNs in clinical practices, 
as exampled below. 
1. New facile, economic mild strategies for the synthesis of MSNs should be 
further explored for their large-scale production. Therefore, it is of great 
importance to design multicomponent nanocomposites for large-scale 
production and with a controlled structure and stable surface chemistry. 
2. Multifunctional MSNs are expected to endow advanced properties such as long 
circulation time, controlled release, drug and gene co-delivery, and eventually, 
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Chapter 3. Fe3O4 encapsulated mesoporous silica 




Magnetic Fe3O4 and mesoporous silica core-shell nanospheres with tunable size from 
110 to 800 nm were synthesized via a one step self-assembly method. The 
morphological, structural, textural, and magnetic properties were well-characterized 
by scanning electron microscopy (SEM), transmission electron microscopy (TEM), X-
ray diffraction (XRD), N2 adsorption-desorption and magnetometer. These 
nanocomposites, which possess high surface area, large pore volume and well-defined 
pore size, exhibit two dimensional hexagonal (P6mm) mesostructures. Interestingly, 
magnetic core and mesoporous silica shell nanocomposites with large void pore (20 
nm) on the shell were generated by increasing the ratio of ethanol/water. Additionally, 
the obtained nanocomposites combined magnetization response and large void pore, 
implying the possibility of applications in drug/gene targeting delivery. The cell 
internalization capacity of NH2-functionalized nanocomposites in the case of cancer 




Magnetic nanoparticles have attracted a great deal of attention, not only for their 
fundamental scientific interest, but also for their many technological applications in 
bio-separation, diagnostic analysis, magnetic carriers for drug-delivery systems, 
magnetically separable catalysts, biosensors and so on.[1,2] However, due to the high 
ratio of surface to volume and magnetization, bare magnetic nanoparticles are usually 
prone to aggregation driven by the decrease of total surface energy.[2,3] Coating with 
ligands, polymers and silica can help to overcome this drawback.[2,4–6] Among these 
coating strategies, mesoporous silica-coated magnetic nanoparticles have become 
increasingly important because of the excellent properties of silica such as  high 
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surface-to-volume ratio, high biocompatibility and biodegradability, easy 
functionalization, controllable porosity and low cytotoxicity.[6–15] 
    Since the early pioneering work in 1992, ordered mesoporous silicas with large 
surface area and porosity, narrow pore size distribution, controlled morphology, and 
high thermal and hydrothermal stabilities have gained much attention due to their wide 
potential applications.[16] The integration of mesoporous silica with magnetic 
particles to form core-shell nanostructures is undoubtedly of great interest for practical 
applications. Several groups have reported the synthesis of monodisperse magnetite 
(Fe3O4) nanocrystals embedded in mesoporous silica spheres.[7–15] The first reported 
magnetic mesoporous silica nanocomposites by Wu et al.[4] were irregular in shape 
and size. In order to improve their morphology, cationic surfactant such as 
cetyltrimethylammonium bromide (CTAB) was employed as not only a stabilizing 
agent for the transfer of magnetic nanocrystals to aqueous phase but also an organic 
template for the formation of highly uniform mesoporous silica spheres.[5,6,9–11]       
However, these materials either show low saturation magnetization values due to the 
difficulty in increasing Fe3O4 mass fraction or possess randomly aligned mesochannels. 
In addition, sandwich structured magnetic silica nanocomposites with large magnetite 
core (100~200 nm) and ordered mesoporous silica shell have been subject to extensive 
research due to their high magnetic response.[13–15] Especially, synthesis of 
superparamagnetic microspheres with Fe3O4 core and SiO2 shell with perpendicularly 
aligned mesoporous channels and their application for water treatment were reported 
by Zhao’s group[17] and Stucky’s group[18] independently. However, there are rarely 
reports on the magnetic silica nanocomposites with well controlled particle size, shell 
thickness and pore size on shell, which is a major challenge in advanced materials 
science. Furthermore, the large-pore sizes on the shell would pave the way for hosting 
larger biomolecules compared with standard mesoporous silica-coated particles with 
2 nm pores. Therefore, the core-shell magnetic mesoporous silica nanospheres with 
large pore size on the shell are highly desirable. 
    In this chapter, we report the synthesis of magnetic mesoporous silica core shell 
nanospheres by combination of microemulsion method and Stöber process as shown 
in Figure 3.1. The diameter and the shell thickness of mesoporous silica spheres can 
be readily adjusted by changing the synthetic parameters. More importantly, the pore 
structure on the shell can be tailored for multi-purpose applications by altering the 
ethanol/water ratio. To illustrate the core-shell nanocomposites for the potential 
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application in nanomedicine, the cell internalization capacity of NH2-functionalized 
nanocomposites in the case of cancer cells (HeLa cells) was investigated. 
 
 
Figure 3.1 The formation of magnetic Fe3O4 and mesoporous silica core-shell 
nanospheres with tunable size (Fe3O4@meso-SiO2-n). 
 
 
3.2 Experimental section 
3.2.1 Chemicals and materials.  
All materials were of analytical grade and used as received without any further 
purification. Tetraethyl orthosilicate Si(OC2H5)4 (TEOS) (>99%), 
aminopropyltriethoxysilane (APTES) (97%), 1-octadecene (90%), 1,2-
hexadecanediol (90%), chloroform (99%), Iron stearic acid (Fe(SA)3),  anhydrous 
ethanol, ammonium hydroxide (25 wt% NH3 in water), and cetyltrimethylammonium 
bromide (CTAB) were purchased from Aldrich. Water was purified by a Milli Q system 
and had an electrical resistance of 18 MΩ·cm. 
 
3.2.2 Synthesis of monodisperse Fe3O4 nanocrystals  
Monodisperse Fe3O4 nanocrystals were prepared according to the reported method.[9] 
In a typical synthesis, iron stearic acid (Fe(SA)3, 2.0 mmol), 1,2-hexadecanediol (9.0 
mmol), and 10 mL of 1-octadecene were heated and stirred until it became a 
homogeneous mixture. The resulting homogeneous mixture was heated and 
crystallized under static conditions at 240 °C in a Teflon-lined autoclave for 6–12 h. 
The synthesized mixture was then allowed to cool down to room temperature. Fe3O4 
nanocrystals were washed with the mixture of ethanol and chloroform for three to four 
times. The precipitate was collected by centrifuging at 4750 rpm for 20 min and 
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suspended in 5 mL of hexane (The concentration of the magnetic nanocrystals is 30 
mg mL-1). 
 
3.2.3 Synthesis of magnetic Fe3O4 and mesoporous silica core-shell nanospheres 
with tunable size  
In a typical experiment, 2.0 mL of Fe3O4 nanocrystals dispersed in chloroform (30 mg 
mL-1) was added to 20 mL of aqueous solution containing 0.16 g of C16TAB. After 
vigorous stirring of the resultant solution, a homogeneous oil-in-water microemulsion 
was obtained. The solution was then heated at 65 °C for 30 min to induce the 
evaporation of chloroform and lead to the formation of aqueous phase dispersed 
nanocrystals. 
    The synthesis of magnetic Fe3O4 and mesoporous silica core-shell nanospheres with 
tunable size was achieved by the ammonia-catalyzed hydrolysis and condensation of 
TEOS in mixed ethanol–water solvents by using CTAB as a surfactant. Typically, 20 
mL of the as-synthesized aqueous phase monodisperse Fe3O4 nanocrystals was added 
into the 61 mL mixture of water and ethanol and stirred at room temperature, and 0.16 
g of CTAB was mixed.  Then 1.0 mL of TEOS and 1.0 mL of ammonia solution (25 
wt% NH3 in water) were added under a stirring speed of 700 rpm at 25 °C. After 3 h 
stirring, the light brown product was collected by centrifugation, washed with water, 
and dried at room temperature. Finally, the surfactant was extracted by refluxing 1.0 g 
of as-synthesized material in 200 mL of ethanol for 24 h. This procedure was repeated 
twice. Six mixtures of water and ethanol with different ethanol-to-water volume ratios 
(V) (26 mL ethanol/35 mL water, V=0.74;  28 mL ethanol/33 mL water, V=0.85; 30 
mL ethanol/31 mL water, V=0.97; 32 mL ethanol/29 mL water, V=1.10; 34 mL 
ethanol/27 mL water, V=1.26; and 36 mL ethanol/25 mL water, V=1.44) were used in 
this study. The samples synthesized using different ethanol/water ratio were denoted 
as Fe3O4@meso-SiO2-n, (n = 110, 200, 420, 600, 650, 800), n is the particle size of the 
sphere as listed in Table 3.1. 
 
3.2.4 Surface modification of magnetic Fe3O4 and mesoporous silica core-shell 
nanospheres  
Typically, 0.6 g of core-shell nanospheres were suspended in toluene (50 mL) with 0.6 
mL of 3-aminopropyltriethoxy silane (APTES; Aldrich), refluxed at 110 °C for 24 h, 
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the solid products were collected via the centrifuge and washed 5 times with acetone 
to remove toluene. The sample was then dried in oven at 50 °C and denoted as 
Fe3O4@meso-SiO2-NH2. 
 
3.2.5 Cell uptake assay  
The assays were carried out in 6-well cell culture plates. HeLa cells were seeded in 
plates at 2 × 105 cells per well the day before the assay. The particles (Fe3O4@meso-
SiO2-NH2-200) were diluted in phosphate buffered saline (PBS) at a concentration of 
1 mg/mL, and 100 μL of the resulting mixture was used for each well. A 21-nucleotide 
long (oligo) DNA conjugated with cyanine dye (Cy-3) was used as a template for short 
interfering RNA (siRNA) and was diluted in the 100 μL of particle solution to give 
final oligo DNA concentrations of 50 nM and 100 nM. The solution was mixed well 
and incubated at room temperature for overnight at 4 °C. After incubation, the particles 
were washed once with PBS, then centrifuged 3 min at 3000 rpm on a desktop 
microcentrifuge followed by two washes with Dulbecco's Modified Eagle's Medium 
(DMEM) supplemented with 10% heat-inactivated fetal calf serum, 100 units/mL 
penicillin G, 100 ug/mL streptomycin sulfate, and 0.29 mg/mL of L-glutamine (Gibco-
Invitrogen), the complete DMEM. The nanoparticles were resuspended in 100 μL of 
complete DMEM and added to each well of 6-well plates containing 1 mL of complete 
DMEM. After 4 h of incubation at 37 °C, the cells were washed 2 times with PBS and 
fixed with 4% paraformaldehyde in PBS (4 °C for 30 min). The cells were washed 
again with PBS and the liquid was drained. A 200 μL portion of antifade fluorescent 
mounting medium with DAPI was added in for staining the nuclei, and the cells were 
viewed under the fluorescent microscopy. 
 
3.2.6 Characterization  
XRD measurements were performed on a Rigaku D/max-2550V diffractometer using 
Co Kα radiation at 30 kV and 15 mA. SEM images of samples coated with platinum 
were recorded on a JEOL 6400 microscope. TEM images were obtained by JEOL 
JEM2100 electron microscope. The powder samples for TEM measurements were 
suspended in ethanol and then dropped onto the Cu grids with carbon films. Nitrogen 
sorption isotherms of samples were obtained by a Quantachrome’s Quadrasorb SI 
analyzer at -196 °C. Prior to the measurement, the samples were out-gassed at 120 °C 
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for at least 6 h. The Brunauer-Emmett-Teller (BET) specific surface areas were 
calculated using adsorption data at a relative pressure range of P/P0 = 0.05~0.25. Pore 
size distributions were derived from the adsorption branch using Barrett-Joyner-
Halenda (BJH) method. The total pore volumes were estimated from the amounts 
adsorbed at a relative pressure (P/P0) of 0.99. Magnetization measurements were 
carried out using a Magnetometer under magnetic fields up to 10000 Oe and at 300 K. 
 
Table 3.1 Physicochemical properties of magnetic mesoporous silicas 
























































































3.3 Results and discussions 
The procedure for the synthesis of Fe3O4@meso-SiO2-n with tunable particle size is 
shown in Figure 3.1. In brief, Fe3O4 nanoparticles in chloroform were firstly 
transferred to the aqueous solution using CTAB as the transferring agent. Secondly, 
CTAB-modified Fe3O4 nanoparticles were dispersed into water and ethanol mixture 
solution by adding ammonia solution. Subsequently, mesoporous silica shell was 
formed via an extension of Stöber method by adding TEOS in the system through the 
hydrolysis and condensation of TEOS around CTAB-modified Fe3O4 nanoparticles. 
Finally, the magnetic silica nanocomposites with large tunable particle sizes were 





Figure 3.2 SEM images of Fe3O4@meso-SiO2-n with different particle sizes: 
a/Fe3O4@meso-SiO2-110; b/ Fe3O4@meso-SiO2-200; c/ Fe3O4@meso-SiO2-420; d/ 
Fe3O4@meso-SiO2-600. 
 
    Figure 3.2 shows SEM images of the Fe3O4@meso-SiO2 composites obtained after 
the removal of CTAB templates. The products have uniform spherical morphology 
and the diameters of the spheres increase with increasing ethanol-to-water ratio. The 
average sizes of Fe3O4@meso-SiO2-110, Fe3O4@meso-SiO2-200, Fe3O4@meso-SiO2-
420, and Fe3O4@meso-SiO2-600 vary in a range of ca. 110–600 nm as observed from 
SEM images. TEM images (Fig. 3.3) further confirm the spherical shape and uniform 
particle size. A typical core–shell structure with Fe3O4 nanoparticles as core and 
ordered mesoporous silica as a shell can be clearly observed. The mesoporous structure 
is uniform and accessible with unobstructed pore entrance on the rough silica surface. 
The physicochemical properties of the Fe3O4@meso-SiO2 particles prepared under 
various synthesis parameters are summarized in Table 1. It can be seen that the sphere 
diameter increases significantly with the amount of ethanol. The samples synthesized 
with a low ethanol-to-water volume ratio (V=0.74~0.85) have ordered hexagonal 
mesoporous structures (Figs. 3.3a-d). The formation of large void pore on shell starts 
at V=0.97, which attributes to the transformation from oil droplets to microemulsion. 
At higher ethanol concentration, high charge density and large head groups of CTAB 
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is tend to form microemulsion, the large void pores are formed by the connecting of 
the small mesopore in the microemulsion. The Fe3O4@meso-SiO2-420 and 
Fe3O4@meso-SiO2-600 shown in Figs. 3.3e-h have a radially oriented 8 nm void pores 
around the hexagonal mesoporous structures. The nanocomposites synthesized with a 
large amount of ethanol (Figs. 3.3i–l) exhibit irregular particle size, randomly arranged 
small mesopores, and ellipsoidal shaped larger void pore around 20 nm. 
 
 
Figure 3.3 TEM images of Fe3O4@meso-SiO2-n with different particle sizes: a, b/ 
Fe3O4@meso-SiO2-110; c, d/ Fe3O4@meso-SiO2-200; e, f/ Fe3O4@meso-SiO2-420; g, 
h/ Fe3O4@meso-SiO2-600; i, j/ Fe3O4@meso-SiO2-650; g, h/ Fe3O4@meso-SiO2-800. 
 
    According to the above results, we propose a possible mechanism for the formation 
of Fe3O4@meso-SiO2 nanocomposites through a simple one-pot approach. After 
addition of TEOS, the electrostatic interactions between silicate oligomers hydrolyzed 
from TEOS molecules and CTAB-stabilized Fe3O4 nanocrystals quickly lead to 
formation of the core–shell Fe3O4 mesoporous silica nanospheres by the assembly of 
silica-surfactant micelles and CTAB-stabilized Fe3O4 nanocrystals.[6,9,15] As 
illustrated in Scheme 1, the effect of  ethanol on the monodispersity and size variety 
of Fe3O4@meso-SiO2-n can be explained. The presence of ethanol slows down the 
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hydrolysis reaction of TEOS and the condensation of silicate-surfactant aggregates on 
the Fe3O4 nanoparticles. At a low ethanol-to-water volume ratio, the particle 
aggregation process is fast and nanocomposites with small particle sizes were formed 
(Figs. 3.3a– d). With higher ethanol concentration, the slow hydrolysis rate of TEOS 
and condensation of silica-surfactant aggregates cause the monodispersity of 
mesoporous spheres with large particle sizes (Fig. 3.3e–h). The microemulsion is 
formed from the unhydrolyzed TEOS to generate large void pores. Too much ethanol 
could cause very slow silicate hydrolysis and condensation, which would decrease 
dispersity, increase the particle size of nanocomposites and induce the connection of 
spheres to each other, as shown in Fig. 3.3k. With increasing ethanol-to-water volume 




Figure 3.4 (A) Small angle and (B) wide-angle XRD patterns of Fe3O4@meso-SiO2-
n with different particle sizes: (a) Fe3O4@meso-SiO2-110; (b) Fe3O4@meso-SiO2-200; 
(c) Fe3O4@meso-SiO2-420; (d) Fe3O4@meso-SiO2-600; (e) Fe3O4@meso-SiO2-650; 
(f) Fe3O4@meso-SiO2-800. 
 
    The low-angle XRD patterns (Fig. 3.4A) of the resulted nanocomposites show one 
or two diffraction peaks, which can be assigned to the 100 and 110 reflections of a 
relatively uniform 2D-hexagonal (P6mm) mesostructure, confirming an ordered 
mesostructure of silica shells. Wide-angle XRD patterns of silica magnetic 
 




















































nanocomposites present five resolved diffraction peaks (Fig. 3.4B), which can be 
indexed to 220, 311, 400, 511 and 440 and attributed to Fe3O4 with space group Fd3m 
according to the JCPDS Card Number 19-629 (JCPDS = Joint Committee on Powder 
Diffraction Standards), consistent with the presence of magnetite Fe3O4 core 
encapsulated in the nanocomposite. Fe3O4@meso-SiO2-650 has stronger intensities for 
all diffraction peaks, suggesting that more Fe3O4 nanocrystals are embedded in 
Fe3O4@meso-SiO2-650. Additionally, the broad peak at around 2θ = 21o indicates the 
presence of amorphous silica in Fe3O4@meso-SiO2-n. The characteristic diffraction 
peaks of Fe3O4 in XRD patterns (Fig. 3.4) together with TEM images (Fig. 3.3) 
confirm the existence of magnetic nanocrystals in mesoporous silica nanospheres. 
 
 
Figure 3.5 A/ Nitrogen-sorption isotherms, and B/ BJH pore-size distribution of 
Fe3O4@meso-SiO2-n with different particle sizes: a/ Fe3O4@meso-SiO2-110; b/ 
Fe3O4@meso-SiO2-200; c/ Fe3O4@meso-SiO2-420; d/ Fe3O4@meso-SiO2-600; e/ 
Fe3O4@meso-SiO2-650; f/ Fe3O4@meso-SiO2-800. 
 
    The mesoporous feature of nanocomposites has been confirmed by nitrogen 
sorption measurement. The nitrogen sorption isotherms of core–shell Fe3O4@meso-
SiO2-n (Fig. 3.5A) show type IV isotherms with a capillary condensation step at low 
relative pressure (P/P0 = 0.2–0.4), suggesting uniform cylindrical mesopores. The pore 
size distribution (Fig. 3.5B) exhibits a sharp peak centred at the mean value of ~2.1 
nm, indicating a uniform mesopore. In addition to the capillary condensation step at 
 

























































P/P0 = 0.2–0.4, Fe3O4@meso-SiO2-n where n = 420, 600, 650, 800, possesses a type-
H4 hysteresis loop at P/P0 values between 0.5 and 0.9. The existence of such a type-
H4 loop might indicate that some void defects are formed in the core-shell 
nanocomposites. The surface area and the total pore volume are calculated to be as 
large as 567 m2 g-1 and 0.49 cm3 g-1, respectively. The surface area and pore volume 
of the resultant Fe3O4@meso-SiO2-n are changed irregularly by tunning the 
ethanol/water ratio. Thus, the relatively high specific surface area, large pore volume, 
and ease of functionalization make them attractive as delivery vehicles. 
    To investigate the magnetization properties of nanocomposites, the samples were 
studied by a magnetometer. Fig. 3.6 shows the field-dependent magnetisation curves 
of three typical nanocomposites, Fe3O4@meso-SiO2-200, Fe3O4@meso-SiO2-420 and 
Fe3O4@meso-SiO2-650 measured from -20 000 to 20 000 Oe at 300 K. The saturation 
magnetization value is measured to be 2.6, 2.5 and 5.0 emu g-1, respectively. The 
relatively low magnetization value is due to the presence of mesoporous silica shell 
and low concentration of magnetic particle, however, the particles show fast response 
toward external magnetic field. The magnetization value could be varied by tuning the 
magnetic particle concentrations. These characteristics are very beneficial to 
bioseparation, biocatalysis and drug/gene delivery applications. 
 
Figure 3.6 Field-dependent magnetization at 300 K of Fe3O4@meso-SiO2-n with 
different particle sizes: a/ Fe3O4@meso-SiO2-420; b/ Fe3O4@meso-SiO2-600; c/ 
Fe3O4@meso-SiO2-650. 
 
    Efficient cellular internalisation of nanoparticles is necessary for intracellular drug 

























application of Fe3O4@meso-SiO2-n in nanomedicine,  the outside surface of  
mesoporous silica shell of Fe3O4@meso-SiO2 are modified by APTES ( denoted as 
Fe3O4@meso-SiO2-NH2-200) to induce  cationic charges which can promote the 
uptake of particles by negative charged cells. Fe3O4@meso-SiO2-NH2-200 was then 
functionalized 21-nucleotide long (oligo) DNA (a model for siRNA) by adsorption. 
To adequately track adsorption and cell internalization process, oligo-DNA was 
labeled with cyanine dye (Cy3). Fig. 3.7 illustrates the cell uptake study of 
Fe3O4@meso-SiO2-NH2-200. It is observed that there is no Cy3 signal from the control 
experiment. The confocal microscopy image of Fe3O4@meso-SiO2-NH2-200 shows 
that most red signals (Cy3) are within the cells, suggesting that a large amount of the 
Fe3O4@meso-SiO2-NH2-200 particles were taken up by HeLa cells. The cell uptake 
results suggest the possibility and efficiency of magnetic mesoporous silica 
nanospheres to deliver drugs into cells for therapy, in addition, they can potentially 
serve as contrast agents in MRI because of their magnetic properties.[15,22-24]   
 
 
Figure 3.7 Confocal microscopic images of intracellular localization in HeLa cells: 
the cell up-take efficiency of Fe3O4@meso-SiO2-NH2-200 was examined by labelling 
the particles with a 21-nt oligo DNA conjugated with Cy-3; the oligo DNA-Cy3 
(DNA-Cy3) or Fe3O4@meso-SiO2-NH2-200 alone is negative for Cy3 signal. 






In summary, we have successfully designed and synthesized magnetic mesoporous 
silica core-shell nanospheres with large void pores and tunable particle sizes for gene 
therapy. The particle size can be tuned from 110 nm to 800 nm by tailoring the ethanol 
to water volume ratio, while the large void pore on shell can be regulated from 8.0 to 
20 nm by increasing ethanol amount. Moreover, the NH2-functionalized magnetic 
mesoporous silica nanospheres could be efficiently internalized into HeLa cell lines, 
which is potentially important for siRNA efficacy against cancer cells. The results 
would provide an application paradigm of magnetic mesoporous silica nanoparticles 
for cell labelling and drug delivery. 
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Chapter 4. Inorganic-salts assisted self-assembly of 





Periodic mesoporous organosilicas (PMOs) have been synthesized through the 
condensation of organosilicates 1,2-bis(trimethoxysilyl) ethane around inorganic-
electrolyte-stabilized Pluronic F127 [(EO)106(PO)70(EO)106] triblock copolymer 
micelles in a sodium bicarbonate (NaHCO3)/sodium carbonate (Na2CO3) buffer 
solution (pH≈9.9). It is found that the addition of inorganic sulfate salts in the synthesis 
is crucial factor to ensure the formation of ordered mesostructures. The addition of 
Na2SO4 and MgSO4 in the synthesis system can lead to the formation of ordered 2-D 
hexagonal (P6mm) and 3-D cubic (Im3m) mesostructure, respectively. The effects of 
other inorganic sulfate salts such as CuSO4, NiSO4, and ZnSO4 have also been 
investigated. Apparently, the interaction between Pluronic F127 micelle and 
organosilica oligomers is enhanced by the presence of these inorganic salts. The 
mechanism for PMOs formation has been proposed on the basis of inorganic salts 
assisted micelles-organosilicates closed packing under mild synthetic condition. The 
findings from this work contribute understanding fundamental understanding towards 
a new formation route of these ordered mesoporous materials, thus providing a new 





Since its first synthesis in 1990, mesoporous materials have attracted increasing 
research attention in materials science.[1-10] Periodic mesoporous organosilicas 
(PMOs) are one of the newly emerging organic−inorganic hybrid materials, which are 
composed of silica frameworks and organic bridging groups.[11-16] Since the 
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pioneering works reported in 1999 by three independent groups,[17-19] much research 
effort has been directed toward the design and synthesis of PMOs with different 
mesostructures, tailored pore sizes, controlled morphologies and functionalities to suit 
different applications.[11, 14, 16] With a series of extraordinary features, such as large 
surface area, uniform dispersion of the organic groups in frameworks, tailored 
properties by changing the bridging organic group, PMOs are becoming one of the 
important  functional nanomaterials for a wide spectrum of potential applications in 
catalysis, optics, biomedicine, adsorption and separation.[11-16]  
Similar to their mesoporous silicas (MPSs) counterparts,[20-25] significant progress 
has been made in understanding the formation mechanisms of PMOs and optimizing 
the synthesis strategy.26-30 To date, various PMOs with different organic bridges have 
been successfully synthesized by involving different surfactants (i.e., cationic, anionic 
or non-ionic) such as Pluronic triblock copolymer (PTC).[11, 16] To explore the 
formation mechanism, cooperative self-assembly, colloidal phase-separation, and hard 
sphere packing routes have been proposed for PTC templating synthesis of 
mesoporous materials via diverse synthesis pathways such as S0I0, S0H+X-I+.[11, 22, 
31] However, the formation process is difficult to be controlled due to the fast 
hydrolysis and condensation rate of silane precursors under strongly acidic conditions 
when involving PTC as a soft template. To overcome this shortcoming, other synthesis 
protocols have been developed by using buffered solutions (e.g. HAc/NaAc, 
NaH2PO4/Na2HPO4, citric acid/citrate) to purposely slow down the formation process 
so the formation mechanism could be easily tracked for fundamental 
understanding.[26, 28, 32-34] In  most of these cases, the pH value of the buffer 
solution is controlled in the range of 3 to 5 after the addition of inorganic salts. 
Recently, Martens and coworkers have reported the packing formation mechanism by 
mastering the formation process of ordered cubic mesoporous silica material (COK-
19) synthesized by using sodium silicate as silane precursor in a citric acid/citrate 
buffered micellar solution (pH≈3.0) of Pluronic F127 [(EO)106(PO)70(EO)106] triblock 
copolymer.[26]     
    Single PTC micelle templating is one of the most commonly used method to 
synthesize silica hollow nanospheres through silica cross-linking followed by PTC 
removal.[28, 31, 35, 36] For example, Liu et al. first demonstrated the synthesis of 
ethylene-bridged organosilicas hollow nanospheres through the cross-linking of 1,2-
bis(trimethoxysilyl)ethane (BTME) onto F127 micelle under a mild buffer condition 
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(NaH2PO4-Na2HPO4, pH≈7.0).[28] Later, it has been confirmed that different 
organosilicas (e.g. methylene, −CH2–, ethylene, −CH2–CH2−, ethenylene, –CH═CH−, 
phenylene, −C6H4− bridged) hollow nanospheres can be obtained by using F127 
micelle template under acidic condition in the presence of TMB.[29, 35] Furthermore,  
a transition from hollow nanospheres to ordered mesostructures can be achieved by 
varying the synthesis parameters such as category of silane, PTC or silane precursor 
concentration, reaction temperature, and addition of inorganic salts.[20, 21, 26-31, 35-
38] For instance, sphere packing formation mechanism has been proposed based on 
these results.[25, 31, 35, 37] However, the effect of the presence of inorganic salts on 
the hollow nanospheres or the ordered mesostructures formation has not been 
systematically  investigated and the role of cationic inorganic salts is still unclear. 
Moreover, all the buffer solution systems currently employed are in weak acidic 
condition, in particular, after the  addition of inorganic salts, under which, the 
hydrolysis and condensation rates of silane  are still too quick to be easily tracked to 
clarify the influencing factors of the process. It is still remains a challenge to develop 
a buffer synthetic strategy with a solution pH value close to neutral after the addition 
of inorganic salts.  
    Herein, we have adopted a single micelle templating synthesis strategy that was 
developed previously[35] to investigate the effects of inorganic salts  on the formation 
of PMOs with different morphology and mesostructures. To our knowledge, this is the 
first time that the synthesis of ordered PMOs by using PTC template under a weak 
basic condition (sodium bicarbonate (NaHCO3)/sodium carbonate (Na2CO3) buffer 
solution pH≈9.9) with the assistance of the inorganic salts has been reported. The 
effect of cationic sulfate on the physicochemical properties of PMOs is studied and 
accordingly, a new formation mechanism based on inorganic salts assisted micelles-
organosilicates closed packing is proposed under moderate synthetic condition. 
 
4.2 Experimental sections 
4.2.1 Chemicals and reagents 
Triblock poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) 
copolymer EO106PO70EO106 (Pluronic F127, Mw = 12600) and 1,2-
bis(trimethoxysilyl)ethane (BTME, 96%) were purchased from Sigma-Aldrich 
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Company Ltd. All materials were in analytical grade and used without any further 
purification. 
 
4.2.2 Synthetic procedure 
In a typical synthesis, 1.0 g of F127, 1.0 g of 1,3,5-trimethylbenzene (TMB) and 40 
mmol of different inorganic sulfate salts (Na2SO4, MgSO4, ZnSO4, NiSO4, CuSO4) 
were dissolved in 60 mL of NaHCO3/Na2CO3 buffer solution (pH≈9.9, 0.050 mol/L 
NaHCO3, 0.050 mol/L Na2CO3) at 40 °C under vigorous stirring. When the copolymer 
was fully dissolved, 2.70 g (10 mmol) BTME was added under stirring. The resultant 
mixture was stirred at the same temperature, which was taken as the reaction 
temperature for 24 h and aged at 100 °C under static conditions for an additional 24 h. 
The solid product was recovered by filtration and air-dried at room temperature 
overnight. Finally, the surfactant was extracted by refluxing 1.0 g of as-synthesized 
material in 200 mL of ethanol containing 1.5 g of concentrated aqueous HCl solution 
for 24 h. The surfactant-free sample was denoted as mesoporous organosilicas (MO-
n) synthesized with addition of different inorganic salts as listed in Table 4.1. 
Table 4.1 The synthetic conditions and physicochemical properties of mesoporous 
organosilicas MO-n, synthesized with addition of different inorganic salts 
 
4.2.3 Characterizations 
X-ray diffraction (XRD) patterns were recorded on a Rigaku RINT D/Max-2500 
powder diffraction system using Cu Kα radiation of 0.15406 nm wavelength at 
40kvX10mA. The nitrogen sorption experiments were performed at -196 °C using a 





































































degassed at 120 °C for at least 6 h. The Brunauer-Emmett-Teller (BET) specific 
surface areas were calculated using adsorption data in a relative pressure range of P/P0 
= 0.05~0.25. Pore size distribution was derived from the adsorption branch using the 
Barrett-Joyner-Halenda (BJH) method. The total pore volumes were estimated from 
the amounts adsorbed at a relative pressure (P/P0) of 0.99. Transmission electron 
microscopy (TEM) was performed using a FEI Tecnai G2 Spirit at an acceleration 
voltage of 120 kV. Scanning electron microscopy (SEM) was undertaken on a JEOL 
JSM-6360 scanning electron microscope operating at an accelerating voltage of 20-30 
kV. The samples were deposited on a sample holder with an adhesive carbon foil and 
sputtered with gold prior to imaging. 
 
 
Figure 4.1 Schematic illustration of the formation of mesoporous organosilicas with 
different structures. 
 
4.3 Results and discussions 
4.3.1 Mesoporous organosilicas hollow spheres  
The mesoporous organosilicas (MO-n) were synthesized under relatively mild  
conditions (sodium bicarbonate (NaHCO3)/sodium carbonate (Na2CO3) buffer 
solution pH ≈ 9.9) with co-assembly of triblock copolymer F127 
[(EO)106(PO)70(EO)106] micelles with inorganic sulfate salts and organosilane [1,2-
Bis(trimethoxysilyl)ethane (BTME)] condensation as shown in Figure 4.1. As shown 
in Figure 4.2a, MO-1 synthesized in absence of any sulfates displays irregular and 
aggregated hollow spheres. The size of the single hollow sphere is around 30 nm. The 
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non-uniform nanostructure formation might be related to the weak interaction between 
F127 micelles and organosilica oligomers under weak basic condition (pH≈9.9, 0.050 
mol/L NaHCO3, 0.050 mol/L Na2CO3) even with the assistance of sodium bicarbonate 
and sodium carbonate. The porous structure is further analyzed by the N2 sorption 
measurement (Figures 4.2b and c). The isotherm curve of MO-1 shows two hysteresis 
loops at relative pressure from 0.65 to 0.80 and 0.80 to 0.98, respectively, which is the 
characteristic of hierarchical porous materials. The primary pore (11 nm) and 
secondary pore (31 nm) may be derived from the internal void of the hollow 
nanospheres and interparticle void, respectively (Figure 4.2c and Table 4.1). In order 
to enhance the interaction between F127 micelles and organosilica oligomers to obtain 
mesoporous organosilicas with ordered structures, the effects of different sulfates 
(Na2SO4, MgSO4, ZnSO4, NiSO4, CuSO4) on the co-assemble process was studied. 
 
Figure 4.2 a), Representative TEM image; b), nitrogen adsorption-desorption 
isotherm curves, and c), pore size distributions of mesoporous organosilicas MO-1 
synthesized without addition of inorganic salts. 
 
4.3.2 Mesoporous organosilicas with ordered structures.  
Small-angle X-ray diffraction (XRD) patterns of MO-2 synthesized in the presence of 
neutral Na2SO4 are shown in Figure 4.3a. One well resolved peak with lattice d spacing 
of 24.5 nm is recognized due to the (100) plane of the 2D hexagonal mesostructured 
(P6mm). Transmission electron microscopy (TEM) image of MO-2 shows the ordered 
hexagonal arrays of mesoporous channels (Fig. 4.3b) and that the size of mesopore is 
not very uniform. N2 adsorption-desorption isotherm and the corresponding pore size 
distribution of MO-2 are shown in Figures 4.3c and 4.3d, respectively. Type IV 
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isotherm with a H1 type hysteresis loop at relative pressure between 0.60 and 0.95 is 
observed, which is a characteristic of mesoporous materials similar to SBA-15.[39, 40] 
The pore size distribution is broad with a maximum at 11 nm and further reveals non-
uniform mesopores, which in good agreement with TEM images. The MO has a BET 
surface area of 663 m2 g-1 and a pore volume of 1.02 cm3 g-1 (Table 4.1). The above 
results demonstrate that ordered hexagonal PMOs (MOs-2) with average pore size of 
11 nm have been obtained by the addition of neutral Na2SO4 as the auxiliary agents. 
 
 
Figure 4.3 a), XRD pattern; b), representative TEM image, c), nitrogen adsorption-
desorption isotherm curves, and d), pore size distributions of mesoporous 
organosilicas MO-2 synthesized with addition of 40 mmol Na2SO4. 
     
    Inorganic salt effect has been investigated for the formation of mesoporous 
silicas.[37, 41-44] It has been found that the addition of inorganic salts can alter the 
critical micelle concentration (CMC) of the surfactants, increase the ionic strength of 
the synthetic solutions, control the microporosity, morphology, hydrothermal stability 
of the resultant mesoporous silicas.[22, 45] However, only the effects of anions from 
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the Hofmeister’s series have been noted by employing alkali metal salts as the 
auxiliary agents.[46, 47] In this study, we investigated the cationic effect of sulfates 
on the formation of mesoporous organosilicas. After the successful preparation of MO-
2 with ordered hexagonal mesoporous structure by using Na2SO4 as the auxiliary 
agents, MgSO4 has been selected as the additive for the preparation of MO-3. 
 
Figure 4.4 a), XRD pattern; b),c) representative TEM images; d), nitrogen adsorption-
desorption isotherm curves, and e), pore size distributions of mesoporous organosilicas 
MO-3 synthesized with addition of 40 mmol MgSO4. 
 
    Figure 4.4a shows XRD profile of MO-3, which reveal three clearly distinctive 
reflections in the range of 0.5–2°. These three low-angle reflections can be indexed 
properly to (110), (200) and (211) reflections of the SBA-16[40, 48] category of cubic 
structure (space group Im3m). TEM images further confirm that the MO-3 synthesized 
by using MgSO4 as the auxiliary agent has cubic mesostructure. As shown in Figure 
4.4b and 4.4c, the representative TEM images viewed along (110) and (111) directions 
reveal that MO-3 is consisted of ordered domains of body-centered cubic (Im3m) 
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structure (Table 1). As shown in Figure 4.4d, the nitrogen adsorption−desorption 
isotherms show a type IV isotherm with an H2-type hysteresis loop, indicating a cage-
like pore shape. These results are in agreement with that previously reported SBA-16, 
[40, 48] suggesting MO-3 is ordered cubic mesostructured organosilicas. A narrow 
pore size distribution with a mean value of 9.8 nm is calculated from the adsorption 
branch (Figure 3e). The MO-3 has a very high BET surface area of 1070 m2 g-1 and a 
pore volume of 1.09 cm3 g-1 as listed in Table 1.  
 
4.3.3 Mesoporous organosilicas synthesized by the addition of ZnSO4, NiSO4 and 
CuSO4 
    Other sulfates such as ZnSO4, NiSO4 and CuSO4 have also been used as auxiliary 
agents in current synthetic condition. It should be noted that the pH value of synthetic 
solution is changed from 9.9 to 6.5, 6.2 and 4.2 after the addition of ZnSO4, NiSO4, 
CuSO4, respectively due to the transition metal ionic effect. As shown in Figure 4.5a, 
XRD patterns of the MO-4 and MO-5 show well-resolved pattern with (110), (200), 
and (211) reflections and characteristic XRD patterns of cubic mesostructured (Im3m 
plain group) with d110 spacing of 14.8 and 17.7 nm for MO-4 and MO-5, respectively. 
The PXRD pattern of MO-6 (Fig. 4.5a) shows two diffraction peaks with d-spacing 
ratios of √3: √11, which can be indexed as the (111) and (311) reflections of FDU-
12 a face-centered cubic mesostructure (Fm3m plain group).[49, 50] Nitrogen 
adsorption isotherms of these samples are shown in Figure 4.5b. All the adsorption 
isotherms of MO-4, MO-5 and MO-6 showbroad adsorption–desorption hysteresis 
loops with capillary condensation steps centered at relative pressures of 0.75–0.85, and 
very steep capillary evaporation steps located at relative pressure around 0.49. These 
isotherms and hysteresis loops are similar to that previously reported mesoporous 
silicas (SBA-16, FDU-12) with cage-like mesopores by Zhao and coworkers.[40, 44, 
49, 50] The average pore size of MO-4, MO-5 and MO-6 is 9.8, 9.7 and 12.5 nm, 
respectively (Table 1). All these organosilicas exhibit very high surface area in the 
range of 794 to 1060 m2 g-1, and large pore volume from 0.78 to 0.91 cm3 g-1. The 
systematic variation in XRD patterns and nitrogen adsorption isotherms suggest the 
occurrence of pore structure changes. Ordered mesoporous organosilicas (MO-3, MO-
4, MO-5) with body-centered cubic Im3m structures has been obtained with the 
addition of inorganic salts such as MgSO4, ZnSO4 and NiSO4, while MO-1 with 
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hexagonal structure and MO-6 with face-centered cubic Fm3m structure can be 
synthesized from the addition of Na2SO4 and CuSO4, respectively. 
 
Figure 4.5 a), XRD patterns; b), nitrogen adsorption-desorption isotherm curves of 
mesoporous organosilicas MO-4, MO-5, MO-6 synthesized with addition of different 
inorganic salts: (A) 40 mmol CuSO4, (B) 40 mmol NiSO4, (C) 40 mmol ZnSO4. 
 
4.3.4 The effects of inorganic salts and the formation mechanism.  
  The above result suggests that the addition of inorganic sulfate can induce a transition 
from irregular aggregated hollow nanosphere to ordered mesostructure. It is interesting 
to note that the cationic of sulfate, appears to determine the structure of the final 
mesoporous organosilicas. As shown in Figure 4.1, F127 micelles with a hydrophobic 
PPO core and hydrophilic PEO shell can be formed in aqueous solution.[20, 26-29, 32, 
35] It has been reported that the salting-out phenomenon can increase the 
hydrophobicity of the PPO block and reduce the hydrophilicity of the PEO block. 
Without addition of sulfates, aggregated hollow spheres were obtained from the 
crosslinking ethane silicas onto F127 micelles with the weak assembling interaction 
provided by the carbonate. The interaction between F127 micelles and ethane silicas 












































PEO shell, which will further facilitate the formation of ordered organosilica-F127 
micelles mesostructures accompanied with organosilicas oligomers to penetrate into 
the PEO layer (Fig. 4.1). Lateral aggregation in a different mesophase results in the 
formed organosilicas with different mesostructures. According to Hofmeister series, 
the salting-out influence for anionic is following the sequence of 
SO42->HPO42->F->Cl->Br->NO3->I->ClO4->SCN-,[47] therefore, sulfates have been 
selected in this study to investigate the cationic effect on the mesostructure formation. 
Cationic metal ions play an important role in the formation of different liquid crystal 
mesophase from micelles. Our results imply that mesophase transformation from 
hexagonal P6mm (by addition of Na+), to body-center cubic Im3m (by addition of Mg2+, 
Zn2+, Ni2+), and then to face-center cubic Fm3m (by addition of Cu2+), occur with the 
addition of different sulfates. Thus, by changing the metal cationic, one can control the 




In conclusion, PMOs with hexagonal, body-center cubic and face-center cubic 
mesostructures have been successfully synthesized in a NaHCO3/Na2CO3 buffer 
solution with the assistance of inorganic sulfates. The influences of cationic metals of 
inorganic salts on the mesostructure of PMO materials have been systematically 
investigated. Sodium bicarbonate (NaHCO3)/sodium carbonate (Na2CO3) buffer 
solution (pH≈9.9) provide a mild synthetic medium to slow down the formation 
process. It has been found that ordered body-center cubic mesotructured PMOs can be 
obtained by the assistance of MgSO4, NiSO4 and ZnSO4. The interaction between F127 
micelles and organosilicas has been enhanced by the inorganic sulfates. The formation 
mechanism of mesoporous organosilicas has been explored and clarified on the basis 
of the micelles-organosilicates closed packing. Overcoming the problems encountered 
by the conventional method with fast hydrolysis and condensation process of 
organosilane, the present synthetic strategy can be more facilely applied to investigate, 
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Chapter 5. Less is more, greener microbial synthesis 




Microbial nano-synthesis has been well established as a green method for the 
sustainable development of nanotechnology. However, the mechanism of this 
biotechnology has to be reconsidered with the increasing realization that 
microorganism culture broth plays a vital role during the synthesis, which may obviate 
the dependence on microbes. Here, we demonstrate that silver nanoparticles (AgNPs) 
could be synthesized in several types of microorganism culture broth (an aqueous 
solution abundant in peptone, yeast extract from Saccharomyces cerevisiae, dextrose 
and other reducing and stabilizing agents) without any specific living microbe 
involvement. Light and high pH values of broth were identified as two critical factors 
in ensuring pure AgNPs formation.  In broths containing NaCl at high concentration 
(0.5 w %), silver chloride was identified as the major intermediate and could be 
converted to AgNPs via one-pot photoreduction. Our broth alone strategy 
dramatically simplifies the conventional microbial nano-synthesis process by cutting 
the use of microorganisms and thus provides a more eco-friendly way for nano-Ag 
preparation. The fundamental understanding of the microbial synthesis mechanisms 
and implementing of complete green methods to fabricate technologically important 




      Recently, silver nanoparticles (AgNPs) have been shown to find usage in a diverse 
range of research applications such as catalysis [1], nano-electronics [2], chemical 
sensor [3] and nanomedicine [4]. Additionally, the increasing demand for a wide range 
of consumer goods and apparel has promoted intense study on AgNPs synthesis. A 
multitude of methods have been established to synthesise AgNPs, including 
conventional chemical reduction [5], spray pyrolysis [6], physical vapour deposition 
[7] and irradiation route [8]. Since most processes described so far are associated with 
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high energy consumption or involvement of toxic chemicals, they are not 
environmentally benign. A green route based on pure biological molecules, such as 
peptide and enzyme, has been used successfully for the synthesis of AgNPs and 
controlling their properties [9-11]. Alternatively, extracts from algae and plants have 
been employed as green reactants for AgNPs preparation. Also, microorganisms such 
as bacteria, yeast and fungi are being rapidly exploited as nanofactories in producing 
various nanomaterials [12-15]. Biogenic AgNPs, either intra- or extracellularly 
fabricated have been intensively investigated due to their potent antimicrobial property 
[16-19]. In a typical microbial process, isolated or genetically engineered microbes 
were firstly cultivated in defined nutritional liquid such as LB [20,21] and GMYP 
media [22]. Most of these nutrient broths contain peptone, yeast extract, dextrose and 
other essential growth factors, some of which possess strong reducing and stabilizing 
capability as reported in the literatures [23,24].  After cell culture, the spent media 
were either discarded with the remaining biomass collected for nanoparticle synthesis; 
or silver salt precursors were added into the spent media with or without the presence 
of the microbes for nano-synthesis. It is generally recognized that specific enzyme(s) 
secreted by specific microbes are significant factors to determine the formation of 
nanoparticles, even though the real mechanism of biogenic AgNPs formation is still 
unclear [25]. We are surprised to see that all microbial approaches heavily rely on 
tedious microorganism maintenance rather than on facile broth environment 
optimization. Although the microbial process has been called “green approach” and is 
becoming a popular theme in current bionanotechnology [26], the conventional 
microbial process is apparently complex and non-economic. Furthermore, the 
synthesis mechanism needs to be reconsidered as the role of broth playing in the 
microbial synthesis has been largely ignored by researchers.  
      Contrary to these conventional methods involving tedious isolation of silver 
tolerant bacteria or manipulation of recombinant microbes, it is advantageous to use 
the culture media alone to prepare AgNPs in a more cost-effective way. We have 
successfully obtained gold nanoparticles (AuNPs) with controllable size and 
morphology in yeast mold broth. We point out that living microbes are not the 
indispensable factors for nanomaterial synthesis in this biological system. Peptone, 
yeast extract and dextrose are identified as more powerful players in reducing and 
stabilizing AuNPs with high yield and narrow size distribution. However, it was quite 
perplexing that silver nanoparticles could not be achieved by applying the similar 
93 
 
protocol for AuNPs synthesis mainly due to the AgCl intermediate formation; thus we 
started to suspect the versatility of this broth alone strategy to synthesize other noble 
metal nanoparticles. Until very recently, pure AgNPs were obtained after extensive 
efforts have been dedicated to clarify the significant effects of light condition and pH 
values. Furthermore, we performed AgNPs synthesis at the presence of unmodified 
Gram-positive and Gram-negative bacteria to verify that AgNPs formation is indeed 
microbe-independent. We are delighted to be able to confirm that the broth alone 
strategy also applies to the synthesis of uniform silver nanoparticles under appropriate 
light and pH conditions. We hope that the results of this research together with our 
previous publication will sufficiently alert the microbial nanosynthesis research 
community about the significant advantages or versatility of this novel microbe-free 
strategy.  
 
5.2 Experimental section 
5.2.1 General  
      Silver nitrate (AgNO3), dextrose, hydrochloric acid and sodium hydroxide were 
purchased from Sigma-Aldrich. All chemicals were of at least analytical grade and 
used as received without further purification. Lysogeny broth (LB), nutrient broth 
(NB), tryptic soy broth (TSB), yeast mold broth (YMB), yeast extract (YE) and 
peptone in powder form were purchased from BD company. Aqueous solutions were 
prepared with deionized (DI) water. 
 
5.2.2 Silver nanoparticle formation 
      Silver nitrate was dissolved in DI water to get a 20 mM stock solution. LB, NB, 
TSB, YMB, YE, peptone and dextrose were dissolved in DI water and autoclaved at 
121°C for 15 min. It took ~ 10 minutes to heat up the autoclave (Siltex 250D) from 
room temperature to 80°C and took additional 15 minutes to reach 121 °C therefore 
the total autoclave operating time was about 1 hour. In a typical procedure for the 
nanoparticle preparation, 5 mL AgNO3 solution was added to 5 mL broth to get final 
[Ag+] concentrations from 0.125 to 2.0 mM. The pH of the broth was adjusted by HCl 
or NaOH. The mixture was then placed inside a shaker at room temperature or 37°C 




5.2.3 Structural characterization of Ag nanoparticles 
      The course of the AgNPs formation was monitored by UV-visible spectroscopy 
(GBC Scientific Equipment). The nanoparticles size and polydispersity were 
characterized by a dynamic light scattering (DLS) using Nano-ZS90 analyzer 
(Malvern). For transmission electron microscopy (TEM), a drop of solution was placed 
on carbon-coated copper grids and air dried. X-ray diffraction analysis was performed 
using a Bruker D8 Advance X-ray Diffractometer with Cu Kα (λ = 1.54Å) radiation. 
The diffracted intensities were recorded from 20° to 85° 2θ angles. Inductively coupled 
plasma optical emission spectroscopy (ICP-OES, Perkin Elmer ICP Optima 2000DV) 
was employed to determine the yield of AgNPs. After two days reaction at 37°C, 3 mL 
sample was dialyzed against 2 L DI water to remove free Ag+ followed by 100 000-
fold dilution before analysis by ICP-OES. Blank and standard solutions of silver nitrate 
were tested together.  
 
5.2.4 Nanoparticle formation at the presence of unmodified bacteria  
      Bacterial strains of Escherichia coli (ATCC 25922) and Bacillus subtilis (ATCC 
23857) were obtained from the American type culture collection (Rockville, MD). The 
bacterial cultures were maintained in trypticase soy broth at 37 °C. AgNO3 was added 
at 0.03 mM. The incubation was carried out under light conditions for 3 h. E. coli cells 
for TEM ultrastructure study were centrifuged, washed, fixed and sliced into ~70-nm-
thick specimen by using a Leica ultramicrotome.  
 
5.3 Results and discussions 
5.3.1 Light-dependent AgNPs formation  
      We firstly investigated whether or not Ag ions can be reduced by original broth in 
the dark. The pH values of the pristine lysogeny broth (LB), nutrient broth (NB), 
tryptic soy broth (TSB) and yeast mold broth (YMB) are 7.0 ± 0.2, 6.8 ± 0.2, 7.3 ± 0.2 
and 6.2 ± 0.2, respectively. Detailed information on sample preparation condition is 
shown in Table 1. Unfortunately, at room temperature, the broth colour alternation 
caused by AgNPs formation was not visually observed even after one month 
incubation. Contrarily, in the presence of ambient light with normal fluorescent lamp, 
after 6 h, stable Ag nanoparticulates were gradually formed in all broths containing 1 
mM Ag+ as the colour of broth was altered from light yellow to brown as displayed in 
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Figure 5.1, indicating the dispersion of the formed nanosized Ag species in the broth 
system [27]. However, such colour variation was not observed when the negative 
control experiment was carried out using pure silver nitrate aqueous solution under the 
same condition. Moreover, with prolongation of incubation time, the colour of broth 
became darker due to the formation of larger and much more AgNPs. We also 
observed that AgNPs formation in NB and TSB were faster than in LB and YM broth 
as indicated by the broth colour.  
 
 
Figure 5.1 Digital images of 1 mM [Ag+] in original or pH12 broths after incubation 
at room temperature for 1 month in dark (D) or under light (L) for 20 hours and 15 
days, respectively. 
 
      In previous AgNPs microbial biogenic studies, some control experiments were 
conducted in the dark [28] and particles were not formed as compared to samples 
exposed to microbes. This is likely the major reason for the broth reducing capability 
to be often ignored and thus too much effort has been misled to engineer the special 
protein expression microbial strains. Even so, the importance of the presence of 
ambient light in reducing Ag+ has been reported [29]. In their study, the authors firstly 
transformed the S. cerevisiae strain EBY100 which overexpressed the hexaglutamic 
acid (E6) peptide; then they employed the yeast cells as biological scaffolds for Ag+ 
reduction. No AgNPs were detected in the E6 cells that being kept in the dark. In 
agreement with the hypothesis from Nam et al., we also speculate that photochemical 
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reduction of Ag may be facilitated after Ag ions bind with the reducing peptides in the 
broth [29].  
      Figure 5.2A shows the UV-visible absorption spectra of Ag nanoparticles formed 
in LB, NB, TSB and YMB after incubation for 15 days at room temperature under 
laboratory light. Two relatively narrow surface plasmon resonance (SPR) peaks at 404 
nm and 416 nm indicated the obvious features of the Ag0 in TSB and YMB, 
respectively. The reduction progress was further monitored by the SPR peak variation. 
The SPR peaks increased gradually in intensity as a function of time but with no 
significant peak shift (data not shown here). For Ag ion reduction in NB, the broader 
optical absorption peaks was shifted to the longer wavelength regime (~422 nm). 
Interestingly, the 1AgLBRT15D sample (X-Ag-Y-RT-Z, where X denotes the Ag+ 
concentration in mM, Y is referred to as the broth name, RT is referred to as room 
temperature and Z denotes the reaction time) displayed a UV-vis spectrum similar to 
that of Ag@AgCl plasmonic nanocomposite [30,31]. These results suggested that in a 
broth containing high content of sodium chloride, AgCl could be formed immediately 
upon the addition of AgNO3 [32] and served as the major intermediate compound 
during AgNP formation [33]. The XRD result is provided in Fig. 2B to understand the 
crystal structures of the samples. Figure 5.2B shows the XRD patterns of samples 
prepared under laboratory light at 37 °C for 24 h. For AgLB and AgTSB samples, they 
both show strong AgCl peaks with undetectable Ag peaks. The peaks at 27.7°, 32.1°, 
46.2°, 54.7°, 57.4°, 67.4°, 74.4° and 76.6° correspond well to the (111),  (200),  (220),  
(311), (222), (400), (331) and (420) planes of the cubic phase of AgCl (JCPDS file: 
31-1238), respectively. The diffraction peaks of Ag could be observed after extending 
the reaction time to 2 days. For AgNB samples, additional peak appeared at 38.2° 
corresponds to the typical cubic phase of metallic Ag (JCPDS file: 65-2871). AgYMB 
samples display major diffraction peaks of AgNPs. In agreement with the above Uv-
vis spectra result, the light is implied as a key factor in transforming AgCl to AgNPs.  
      Apart from qualitatively verifies the formation of various noble metal 
nanoparticles, UV-vis spectroscopy is also a facile method to indicate the synthesis 
yield of nanoparticles. In Figure 5.2A, with the same final concentration of [Ag+] (1.0 
mM), the intensity of the maximum absorption band in our system is much larger than 
those of AgNPs synthesized by white rot fungal strain C. versicolor [34]. Further ICP-
OES quantitation of silver reveals that after two days reaction at 37 °C, LB, NB, TSB 
and YM broth converted 70%, 30%, 55% and 40% of silver nitrate to silver colloids, 
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respectively.  It should be noted that at original pH, silver nanoparticle decorated silver 




Figure 5.2 The UV/vis absorption spectra (A) and XRD patterns (B) of nano-Ag in 
various original broths after incubation at room temperature for 15 days. Detailed 
information regarding sample preparation condition is shown in Table 5.1.      
 
Table 5.1 The individual ingredients concentration (w % in water) of broths employed 






Figure 5.3 (A) pH-dependent UV-vis absorption spectra of 2.5 mM AgNO3 reduced 
in TSB of various pH values for 6 h at room temperature. The UV/vis absorption 
spectra (B) and XRD patterns (C) of 1 mM AgNO3 reduced in pH 12 broths.      
 
5.3.2 pH-dependent AgNPs formation 
      We systematically investigated the Ag nanoparticle formation in broths with 
different pH values. For example, Figure 5.3A shows absorption spectra of 2.5 mM 
Ag ions reduced in TSB broth with pH value from 4 to 12. It is found that pH 10~12 
broths enabled the quick particle formation with narrower size distribution (Fig. 5.4). 
Figure 5.3B displays the spectra of AgNPs formed in pH 12 of LB, NB, TSB and 
YMB. A strong plasmonic band appeared at ~ 400 nm for AgLB12, AgTSB12 and 
AgYM12 samples, which was shifted to 430 nm for AgNB12 sample. This is 
consistent with the observation of XRD patterns as displayed in Figure 5.3C. The 
diffraction peaks ascribing to Ag and AgCl are both clearly present for AgLB12 
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sample. As compared to AgLB12 sample, the XRD patterns of other samples signal 
the major phase of metallic Ag. It has been reported that Ag2S phase and Ag phase 
coexisted in the product obtained by employing C. versicolor [34]. In our study, there 
was no peak observed at 2θ = 33.3°, 39.2°, 46.2° that correspond to Ag2S phase. In 
this sense, the broth-only process is promising due to its potential in providing 
relatively pure AgNPs.        
             
Figure 5.4 pH-dependent silver nanoparticle size distribution in TSB broth after 18 h 
incubation at room temperature. Dynamic light scattering results revealed that uniform 





       
Figure 5.5 SEM and EDS results of colloidal silver particulates formed in original LB 
broth (A) and NB broth (B). Initial [Ag+] = 1 mM and all the reactions were carried 
out in a shaker at 100 rpm, 37 °C for 24 h.    
 
    The morphologies of the particles obtained in pristine broths were observed using 
SEM. Taking 1AgLB37C24h and 1AgNB37C24h as examples, as shown in Figure 
5.5, we can see that spherical nanoparticles with an average size of ca. 20 to 50 nm 
were synthesized. The composition of the NPs was determined by energy-dispersive 
X-ray spectroscopy (EDS), all of which show peaks of Ag and Cl. However, the SEM 
images could not be clearly taken because exposure of the Ag@AgCl particles to the 
electron beam caused a reduction of the AgCl to metallic Ag [35]. 
    The most uniform AgNPs were formed in YM12 broth. Figure 5.6 displays the 
optical images and TEM image of 1AgYM12 and a magnified high-resolution (HR) 
TEM image of an isolated AgNP, respectively. The lattice fringes were separated by 
0.23 nm, usually assigned to {111} plane of silver. EDS spectrum shows the 
occurrence of silver with phosphorous and sulphur, mirroring the important role of 
phosphorus and metallothioneins (MTs) or their fragments in the reducing and binding 
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of Ag+ [36]. MTs could be originated from the autolyzed Saccharomyces cerevisiae 
yeast.  
          
Figure 5.6 Silver nanoparticles formed in pH12 YM broth. (A) The optical images of 
nano-Ag in YM broth with initial [Ag+] from 0.125 to 2 mM; (B) TEM image of the 
uniform silver nanoparticles and the corresponding EDS spectrum of nano-Ag(C); (D) 
HRTEM images of an isolated AgNP.  
       
5.3.3 Identification of components in the broth for AgNP formation and 
possible biosynthesis mechanism 
      In our previous work, the reduction of Au3+ was completed by the active species 
in the broth like dextrose, yeast extract (YE) and peptone [24]. The aqueous solution 
of these components was individually or mixed together to reduce Ag+ in this study. 
The UV-vis spectra recorded for a 1 mM Ag+ after 2, 6 and 54 h of reaction at 37 °C 
with the presence of 0.25% dextrose (same dextrose concentration in TSB) showed no 
absorption in the 350-850 nm region, whereas the 0.5%YE, 1%YE+0.3% dextrose and 
0.5%YE+0.25% dextrose produced a gradual increase in absorption band centered at 
ca. 420 nm. Notably, the position of major peak did not change at this wavelength (Fig. 
5.7). These evidences implicate that yeast extract, concentrated from autolyzed 
Saccharomyces cerevisiae, is more powerful than dextrose in reducing Ag+ under 





Figure 5.7 Nano-Ag formed in aqueous dextrose (DE), yeast extract (YE) or mixture 
of DE and YE. The compositions of 1, 2, 3 and 4 are: 1. 0.25% DE ; 2.   0.5%  YE; 3.  
1.0%YE + 0.3%DE ; 4.  0.5%YE + 0.25% DE. 
 
      In order to investigate the relationship between the AgNP formation and pH 
environment of the broth, pH of dextrose solution was adjusted to 12 by adding NaOH 
solution. Surprisingly, at room temperature, AgNPs were formed immediately as 
compared to dextrose solution at pH 5.5. Figure 5.8B recorded the continuous AgNP 
evolution from 10 s to 300 s. However, aggregation occurred within 2 h as indicated 
by DLS results (Fig. 5.8A). The SEM images clearly indicate the well dispersed AgNP 
fused together and formed microsized Ag plates (Fig. 5.8C-D). This is an important 
observation as we may explain the reason why in high pH broths, the major phase of 
nanohybrids was Ag but not AgCl. At high pH, both Ag and AgCl were instantly 
formed upon the addition of precursor solution. However, at neutral pH value, only 
AgCl was quickly yielded and it requires long time to change to AgNPs driven by the 
light. Also, it is clear from this result that yeast extract, peptone or other digested 
proteins play pivotal roles not only in the reduction of Ag+ but also in preventing the 
agglomeration of Ag particles during the reduction process.      
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Figure 5.8 Nano-Ag formed in pH 12dextrose (DE). (A) DLS results of Ag 
nanoparticles; (B) UV-vis spectra of nano-Ag recorded from 10 seconds to 300 
seconds. The initial well-dispersed nano-Ag (C) aggregated into Ag-nanoplate (D) in 
2 h.  
 
5.3.4 Microbe-independent formation of silver nanoparticle  
      To further verify that our greener process is microbe-independent, 0.03 mM silver 
nitrate was incubated with native E. Coli (ATCC25922) instead of the recombinant 
one. Silver nitrate of 0.03 mM was chosen because this is the maximum tolerable 
concentration of Ag ions to E. coli in the dark. After exposing the E. coli and Ag+ 
containing TSB broth to natural light, silver nanoparticles were synthesized extra-
cellularly as indicated by the increased 420 nm absorbance intensity (Fig. 5.7C). To 
check whether or not AgNPs were formed inside the cells, the cell pellets were 
centrifuged and washed for ultrastructure study by TEM. In contrast to silver-resistant 
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Pseudomonas stutzeri AG259 cultured in the presence of 50 mM AgNO3, for which 
the majority of the AgNPs were deposited in the periplasmic space of the cells [20], 
the size of the AgNPs in our study was smaller and distributed evenly all over the cell 
body (Fig. 5.9A). The control experiments without Ag+ showed no AgNPs formation 
(Fig. 5.9B). Importantly, extracellular AgNPs were formed in TSB containing either 
E. coli or B. subtilis, thereby echoing that broth alone strategy is indeed microbe-
independent (Fig. 5.10).     
 
 
Figure 5.9 TEM images of thin sections of wild type E. coli (ATCC25922) cells after 
incubation with Ag+ (A) and without Ag+ (B) for 3 hours confirmed intracellular 
formation of silver nanoparticulates.  
 
      With all the above results in mind, we propose the following mechanism to explain 
the AgNPs formation in microbial cultivation broths in particular with high content of 
sodium chloride (0.5 w %), such as LB and TSB. When AgNO3 solution was added 
drop-wise into broth, AgCl colloid could be formed immediately. UV photoconversion 
of AgCl to AgNPs mediated by DNA template has been reported by Wang et al. [37]. 
The authors have proposed the photosensitivity of AgCl towards the fast formation of 
AgNPs may be realized by visible light irradiation accelerated by specific dyes or color 
sensitizers. Along the same line, we speculate that on absorbing a photon, AgCl 
nanoparticle could generate an electron-hole pair, followed by e- and Ag+ combination 
and Ag cluster species evolution in the presence of peptide or protein: 
hν + Cl- → Cl + e-            (1) 
e- + Ag+ → Ag0            (2) 
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      Although further investigation is still needed, we propose that metallothioneins 
(MTs), having capacity of binding Ag species and scavenging superoxide and 
hydroxyl radicals [38], could accelerate the transformation of AgCl to AgNPs.  To our 
knowledge, this is the first report about the broth-mediated AgNPs formation through 
the intermediate crystalline AgCl colloids.  
Figure 5.10 Nano-Ag formed extracellularly in TSB broth at the presence of E. coli is 
confirmed by recording the optical density at 420 nm.  
 
    Commonly accepted mechanism of extracellular AgNPs formation is the nitrate 
reductase enzymatic reduction [39]. Based on this assumption, much work has been 
dedicated to screening silver tolerant bacteria or genetically engineering special 
microbial species [17,21]. Our new findings have challenged these long-held 
viewpoints that microorganisms are predominantly responsible for the biogenic 
AgNPs. It is safe to affirm that the biomass including fungi and bacteria catalyse the 
AgNPs formation only when the reaction is conducted in broth-free system and in the 
dark condition [40]. AgNPs are formed in the minute to hour timeframe (depending 
on the pH, temperature and light condition, some of the data not shown in this 
manuscript) in our microbe-free process. However, it may take 3 days to obtain AgNPs 
by employing biomass as catalyst. The biomass must be maintained and cultured in 
different media, which are the starting materials that used in our microbe-free process. 
The high-yield and easier downstream particle separation apparently support that our 
technology is superior in producing uniform AgNPs faster, less labour-intensive and 




Here we report a facile and novel protocol to synthesise AgNPs in various microbe 
culture broths. The broth ingredients provide an ideal environment for the formation 
of AgNPs with uniform size distribution. The significant influences of some important 
parameters include light condition and broth pH values have been investigated 
systematically. Whilst sharing similar advantages with the conventional microbial 
processes to use non-hazardous chemicals, this method is of particular importance as 
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Chapter 6. One-pot synthesis of raspberry-like 




Mesoporous materials with hierarchical morphologies have recently gained attention 
due to their structural versatility for various applications including catalysis, 
adsorption, energy storage and nanomedicine. However, it is still desirable for 
controllable synthesis of mesoporous particles with tunable surface properties and 
oriented hierarchical structures. Here, we report a one-pot synthesis method for 
raspberry-like mesoporous silica nanospheres with 2 nm hollow silica nanoparticles 
doped on the surface. We identify that the control over the concentration of cationic 
surfactant and silica precursor can be used to control the multiple morphological 
evolutions of mesoporous silica nanoparticles. This control enables the fabrication of 
a diverse library of multi-compartment mesoporous silicas networks consist of 
mesoporous silica nanospheres connecting with mesoporous silica branches. The 
synthesis method would enable to synthesize hierarchical mesoporous silicas with 
complex architecture and different pore environments for the potential application in 




Natural nanomaterials such as bone, cells, lotus, rose, fish skins, gecko feet exhibit 
multi-scale hierarchical structures.[1-6] Learning from nature, materials scientists and 
chemists have been developing different strategies to fabricate artificial nanomaterials 
with hierarchical structures for mimicking the functionality of natural nanomaterials.5-
8 As one of the typical examples, mesoporous silica nanoparticles (MSNs) have 
attracted widespread interest because of their versatile applications in catalysis and 
nanomedicine.[4, 9-14] In the last decades, a variety of MSNs with different 
morphology have been explored, including rods, spheres, plate, hollow and yolk shell 
particles.[12, 15-24] Among them, raspberry-like mesoporous silica nanospheres 
(RMSNs) with many small particles decorating on the surface of one large particle are 
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of particular interest owing to their hierarchical structures and tunable surface 
properties.[16, 23, 25-31] By mimicking the surface of lotus leaves, raspberry-like 
silicas have been used as antifogging or self-cleaning coatings.[23, 32-36] 
    Many synthetic strategies have been developed for the fabrication of raspberry-like 
nanoparticles. The most common approach is the two step method by assembling 
smaller nanoparticles onto one large core particle through different types of 
complementary interactions. For example, Scherman and co-workers reported the 
synthesis of raspberry-like hollow silica microspheres with paramagnetic Fe3O4 
nanoparticles decorating on the shell by utilizing host–guest complexation of 
cucurbit[8]uril (CB[8]).[25] Zhao et al. demonstrated the synthesis of monodisperse 
raspberry-like hierarchical silica particles through a microfluidic approach.[28] By 
using a vesicle or emulsion template, the one-pot synthesis of raspberry-like 
hierarchical siliceous hollow spheres has also been reported previously.[27, 29] 
Despite the existing library of geometrical variations of raspberry-like silica 
nanoparticles, in most of cases, it is focusing on the hollow silica particles, it is still 
necessary to exploit a simple and practical route for the synthesis of RMSNs. 
In this chapter, we present a simple one-step extension Stöber method for the 
synthesis of raspberry-like and multi-compartment mesoporous silica nanoparticles. 
The effects of several synthesis parameters, such as the concentration of 
cetyltrimethylammonium bromide (CTAB) and silica precursor, water to ethanol ratio, 
on the morphology evolution of final mesoporous silicas particles have been 
investigated. The fundamental understanding of synthesis mechanisms reveals their 
potential for controllable synthesis multi-compartment mesoporous silica 
nanoparticles in the fields of catalysis and nanomedicine. 
 
6.2 Experimental sections 
6.2.1 Chemicals and reagents 
All materials were of analytical grade and used as received without any further 
purification. Tetraethyl orthosilicate Si(OC2H5)4 (TEOS) (>99%),  anhydrous ethanol, 
aqueous ammonia solution (28 wt%), and cetyltrimethylammonium bromide (CTAB) 
were purchased from Aldrich. Water was purified by a Milli Q system and had an 
electrical resistance of 18 MΩ·cm.  
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6.2.2 Synthetic procedure 
Monodisperse raspberry-like mesoporous silica nanospheres (RMSNs) was 
synthesized by extension of Stöber method. In a typical synthesis, 150 mg of CTAB 
was dissolved into a solution containing 30 mL of absolute ethanol (EtOH) and 50 mL 
of deionized water (H2O), then, 0.5 mL of ammonia aqueous solutions (NH4OH, 28 
wt%) was added into the above solution. After stirring for 2h, 0.24 mL of TEOS was 
added to the solution and stirred for 24 h at room temperature, and subsequently heated 
for 24 h at 100 °C under static conditions in a Teflon-lined autoclave. The solid 
products were collected by centrifugation and washed with ethanol and water, 
respectively. The CTAB surfactant was removed by calcinations of the samples at 550 
°C for 6 h. 
6.2.3 Characterization 
Field-emission scanning electron microscopy (FESEM) was undertaken on a 
HITACHI S-4800 microscope operating at an accelerating voltage of 1-30 kV. TEM 
images were obtained by JEOL JEM2100 electron microscope. The powder samples 
for TEM measurements were suspended in ethanol and then dropped onto the Cu grids 
with carbon films. Nitrogen sorption isotherms of samples were obtained by a 
Quantachrome’s Quadrasorb SI analyzer at -196 °C. Prior to the measurement, the 
samples were out gassed at 120 °C for at least 6 h. The Brunauer-Emmett-Teller (BET) 
specific surface areas were calculated using adsorption data at the relative pressure 
range of P/P0 = 0.05~0.25. Pore size distributions were calculated from adsorption 
branch using the Barrett-Joyner-Halenda (BJH) method. The total pore volumes were 
estimated from the amounts adsorbed at a relative pressure (P/P0) of 0.99.  
 
Figure 6.1 Schematic illustration of the synthesis process and formation mechanism 
of raspberry-like mesoporous silica nanospheres (RMSNs). 
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6.3 Results and discussion 
 
Figure 6.2 a) SEM and b)-d) TEM images of typical raspberry like mesoporous silica 
nanoparticles synthesized at CTAB concentration of 5.1 mM. 
 
6.3.1 Synthesis of raspberry-like mesoporous silica nanospheres. 
The well known Stöber method has been widely used for synthesis of silica and 
resorcinol formaldehyde resins spheres.[37] In this study, monodisperse raspberry-like 
mesoporous silica nanospheres (RMSNs) were obtained by extension of this synthetic 
strategy, the typical synthesis of RMSNs was schematically illustrated in Figure 6.1. 
Hollow silica nanoparticles are proposed to be formed on the surface of mesoporous 
silica spheres with the aid of an ammonium catalyst due to the different hydrolysis and 
condensation rates, forming a raspberry-like core–shell structure, denoted RMSNs. 
The typical scanning electron microscopy (SEM) and transaction electron microscopy 
(TEM) of RMSNs are shown in Figure 6.2. The spherical particle size of RMSNs is 
around 360 nm in diameter, these RMSNs are monodisperse, and the surface is rough 
with raspberry-like morphology (Figs. 6.2a and 6.2b). From the TEM images with high 
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resolution (Figs. 6.2c and 6.2d), a disordered worm-like mesoporous structure can be 
clearly seen. The surface of the raspberry-like shell is decorated with hollow silica 
nanoparticles with void size around 2 nm (Fig. 6.2d). Figure 6.3a displays N2 sorption 
isotherms of RMSNs, which shows a type IV isotherm with capillary condensation at 
relative pressure P/P0 between 0.15 and 0.30, indicating uniform mesopores, the 
narrow pore size distribution verifies the uniform pore size of RMSNs (Fig. 6.3b). 
RMSNs has a BET surface area of 435 m2 g-1, a pore volume of 0.24 cm3 g-1, and a 
pore diameter of 1.7 nm. The above characterizations suggest that raspberry-like 
mesoporous silica nanospheres has been successfully prepared. 
 
Figure 6.3 a) Nitrogen adsorption-desorption isotherms and b) pore size distribution 
of typical raspberry like mesoporous silica nanoparticles synthesized at CTAB 
concentration of 5.1 mM. 
 
6.3.2 Effect of CTAB concentration 
Cationic surfactant CTAB has been well recognized as micelle template for the 
formation of mesoporous silicas. In addition, it is well known that CTAB as a 
surfactant plays key role of the nanoparticle morphology. Therefore, the influence of 
different concentrations of CTAB on the formation of mesoporous silica nanoparticles 
has been investigated. As demonstrated in Figure 6.4, it was found that multi-
compartment mesoporous silicas spheres connected by mesoporous silicas bridges are 




400 nm in diameter (Fig. 3). Moreover, higher magnification image reveals that the 
mesoporous silica bridges are around 150 nm in width. With increasing the 
concentration of CTAB to 5.1 mM, RMSNs were formed. While further increasing the 
concentration of CTAB to 6.8 mM, it is clearly observed that the particle size of 
resultant RMSNs is reduced to around 300 nm. More interestingly, large void pore of 
20 nm is coexistence of mesopore as shown in the high magnification TEM image. 
The formation of void mesopores has also been reported in the previous reports with a 
similar synthesis system and higher CTAB concentration.[38, 39] These multi-
compartment mesoporous silicas with hierarchical structures will be crucial for their 
further application in catalysis and nanomedicine, for example, to mimic cells, 
selectively loading different active sites onto different compartments in the silicas to 
construct nanoreactors.[21, 23, 31, 40, 41] 
 
 
Figure 6.4 TEM images of mesoporous silica nanoparticles synthesized at different 
concentrations of CTAB. 
 
6.3.3 Effect of TEOS concentration 
Generally, it is believed that the silica precursor such as TEOS concentration also have 
a significant influence on the morphology and structure of final mesoporous silicas. In 
this study, the influence of different amounts of TEOS on the formation of mesoporous 
silicas has been studied. Figure 6.5 shows the TEM images of the samples prepared at 
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0.36 mL TEOS while keeping the other parameters consistence with RMSNs. 
Raspberry-like mesoporous silicas nanospheres with rough surface and larger particle 
size (~400 nm in diameter) are formed as the amount of TEOS increased. As the TEOS 
amount increased, mesoporous silica nanobridges were formed as presented in Figure 
6.5, the nanobridges with 78 nm in width is thinner than the products formed with low 
CTAB concentration shown in Figure 6.3. Furthermore, no solid product can be 
obtained with reducing the TEOS amount less than 0.1 mL. 
 
Figure 6.5 a), b) TEM images of mesoporous silica nanoparticles synthesized at 
concentrations of CTAB 5.1 mM and 0.36 mL of TEOS. 
 
6.3.4 Effect of H2O/EtOH ratio 
In the Stöber process, the particle size can be varied by tuning the synthesis parameters 
such as ammonia solution concentration, precursor concentration, as well as water to 
alcohol ratio.37 In addition, it is reported that the hydrolysis and condensation rates of 
a silane precursor can be accelerated by adding of alcohol. Therefore, the effect of the 
volume ratio of water to ethanol on the formation of RMSNSs has been investigated 
with other conditions fixed. Similar to other Stöber processes, the particle size is 
increased to around 600 nm as the volume ratio of water to ethanol was decreased from 
1.67 to 1 (Fig. 6.6a, b). The resultant mesoporous silicas were composed of aggregated 
dendrimer-like porous spherical particles as shown in their corresponding TEM 
images (Fig. 6.6a). The enlargement of mesopore size by increasing the alcohol 
amount is in agreement with previous reports. While the volume ratio of water to 
ethanol was increased to 3, the particle size of the resultant mesoporous silicas spheres 
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is decreased to around 100 nm (Fig. 6.6c, d). The shape of spherical silica particles is 
irregular with aggregation can be observed (Fig. 6.6c). The worm-like mesostructured 
of silicas spheres is observed in the TEM image (Fig. 6.6d). The results shown above 
reveal that by increasing the ratio of water/ethanol, the particle size is gradually 
decreased, which is consistence with other Stöber processes.  
 
Figure 6.6 TEM images of mesoporous silica nanoparticles synthesized at 
concentrations of CTAB 5.1 mM and a), b) water to ethanol ratio of 1, c), d) water to 
ethanol ratio of 3. 
 
It has been suggested by previous report that spherical particles can be formed 
through a Stöber process, in particular with suitable alcohol added. As depicted in 
Figure 6.1, the formation mechanism of mesoporous silica particles might be the 
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following four steps, i). 2 to 3 nm micelles of CTAB are formed; ii). after addition of 
TEOS, the hydrolysis and condensation of TEOS onto the CTAB micelles tend to 
generate silica monomers surrounding the micelles; iii). during the stirring and further 
reaction, silica monomers further condense onto the emulsion droplets derived from 
ethanol and water to generate mesoporous silicas spheres; iv). the formation of 
raspberry-like mesoporous silica spheres is possible due to the assembling of unreacted 
silica monomers onto mesoporous silica spheres. Decrease of the concentration of 
CTAB or increase of the amount of TEOS could promote the anisotropic nucleation 




In the present study, we have successfully prepared raspberry like mesoporous silicas 
with particle size of 360 nm through an extension Stöber process. By precisely 
controlling the synthesis parameters, either decreasing of CTAB concentration or 
increasing TEOS amount, multi-compartment silicas with mesoporous silica spheres 
bridged with mesoporous silica rods can be fabricated. It is found that the particle size 
of mesoporous silica can be tuned from 100 to 600 nm by varying the water to ethanol 
ratio. Specifically, the present strategy allows an easy way to generate the hierarchical 
nanostructured silicas by mimicking the structures of diatom cells for the potential 
application in catalysis and nanomedicine. Further studies are currently in progress in 
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Chapter 7. Raspberry-like hollow carbon 





Utilising non solid nanoparticles and material design to create morphologies with 
special surface properties can lead to more advanced applications. Here, resorcinol 
formaldehyde (RF) polymer resins have been successfully coated on the silica spheres 
by the extension of Stöber method, to generate raspberry-like silica@RF core-shell 
particles with a rough surface. After carbonization of the shell and removal of silica, 
uniform raspberry-like hollow carbon spheres were obtained. A competitive process 
between homogenous nucleation and uniform surface coating is proposed as the 
mechanism for formation of the raspberry-like morphology. By finely controlling the 
water/ethanol ratio, a series of hollow carbon spheres with different surface properties 
and patchy structures can be synthesized with this method. The raspberry-like hollow 
carbon spheres demonstrate much better performance than hollow carbon spheres 
with a smooth surface in matrix-free peptide detection due to their high capability to 




Colloidal materials have been studied in several research areas encompassing 
chemistry, materials science, condensed matter physics, applied optics, fluid 
dynamics, and biology because of their widespread applications such as in photonic 
crystal materials, optical sensing, and drug delivery.[1-3] In particular, hollow carbon 
colloidal nanospheres (HCCNs) with controlled diameters, shell thickness and surface 
properties have attracted a great deal of attention due to their unique properties, e.g., 
excellent chemical and thermal stability.[1, 3-10] HCCNs are promising materials with 
a variety of applications including adsorbents,[11-13] super-capacitors,[5, 10, 13-17] 
electrodes of fuel cells and lithium-ion batteries,[18-24] cell delivery[3] as well as 
supports for catalytic system.[9, 10, 14, 19, 25-27]    
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    HCCNs have been synthesized either by hard or soft templating methods.[3, 4, 6, 7, 
9, 11, 12, 14, 28-30] For instance, Lu and co-workers developed a confined nanospace 
pyrolysis method for the synthesis of discrete and highly dispersible HCCNs.[28] In 
their method, a dual core–shell structure particle was first synthesised by surface 
coating of monodisperse polystyrene (PS) nanosphere seeds with a phenol-containing 
polymer (PF), followed by a silica coating process. Dispersible and uniform HCCNs 
were obtained by subsequent pyrolysis of PF and removal of silica. Hollow carbon 
spheres with different particle size, shell thickness and layers have been also prepared 
through a hard templating method involving silica spheres as a template and PF as a 
carbon precursor.[4, 6, 8, 31] By ultilisation of a soft templating method through an 
aqueous emulsion co-assembly, Zhao and co-workers reported the synthesis of multi-
shelled hollow carbon spheres.[7] 
    Most previous reports on HCCNs have focused on the sole aim to obtain hollow 
structural units and particle uniformity but little information has been provided with 
regards to the carbon surface properties. In fact, controllable synthesis of HCCNs with 
adjustable surface properties to suite more applications is still a challenge, for example, 
growing nanoparticles on the surface of cores rather than forming a fused shell. 
HCCNs with rough surface are of critical importance for both the fundamental study 
of carbon colloids and many practical applications such as colloidal catalysts, drug 
carriers, peptide enrichment, nanodevices and ink. However, to date and to the best of 
our knowledge, no raspberry-like HCCNs have been reported. 
    Carbon precursors have an important effect on the preparation and final physical 
and chemical properties of HCCNs prepared by the hard templating method. High 
carbon yield and uniform coating are two critical criteria for the carbon precursor 
selection. Phenolic resins are widely used as the carbon precursor for the synthesis of 
a variety of nanostructured carbons because of their high carbon yield and versatile 
chemical properties. For instance, Liu et al. successfully synthesized monodisperse 
polymer spheres from resorcinol–formaldehyde (RF) resin and carbon spheres by the 
extension of the “Stöber” method.[32] However, it is still a great challenge to precisely 
control the surface properties of the resultant polymer resin spheres due to the high 
concentration of the RF precursor used. In addition to the synthesis of colloidal silica 
spheres, Stöber method also has been widely used for uniform surface coating with 
silica. HCCNs can be synthesized through a hard template method by using either RF 
or dopamine as the carbon precursors. Inspired from this, herein, we report the 
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synthesis of hollow carbon spheres with different surface roughness by controlling the 
two competitive processes: the formation of free Stöber RF spheres and the uniform 
coating of RF on the silica surface. The essence of our method lies in the exploitation 
of 1) the controllable competitive process of homogeneous nucleation and surface 
uniform coating and 2) high carbonization yield of RF. 
 
7.2 Experimental sections 
7.2.1 Synthesis of Stöber spheres 
In a typical procedure, 9 mL of ammonia aqueous solution (NH4OH, 25 wt%) was 
dissolved in a mixture 16.25 mL of ethanol and 24.75 mL of water, stirred at room 
temperature for 5 mins to prepare the solution A and solution B was prepared by 
mixing 4.5 mL of TEOS in 45.5 mL ethanol and stirred at room temperature for 5 mins. 
The silica spheres were separated by centrifugation and rinsed thoroughly with water 
and ethanol. 
 
7.2.2 Synthesis of silica@RF nanospheres 
In a typical protocol, 200 mg 360 nm silica spheres were dispersed in a mixture of 
ethanol and water with a total volume of 28 mL; then 0.1 mL of ammonia aqueous 
solution (NH4OH, 25 wt%) and 1 mL of 0.01 mol/L CTAB solution were added and 
stirred for more than 1 hour. Subsequently, 0.05 g of resorcinol was added and 
continually stirred for 30 mins. The 0.07 mL of formaldehyde solution was then added 
to the reaction solution and stirred for 24 h at 30 °C, and subsequently heated for 24 h 
at 100 °C under a static condition in a Teflon-lined autoclave. The silica@RF spheres 
were separated by centrifugation and washed three times with water. 
 
7.2.3 Synthesis of hollow carbon nanospheres 
The as-made silica@RF was heated at 5 °C /min from room temperature to 350 °C and 
held at this temperature for 1 h under a nitrogen flow. The temperature was then 
ramped at 5 °C /min to 600 °C and held at this temperature for 2 h. The pyrolyzed 




7.2.4 Enrichment tests 
The as-prepared HCCNs show promising potential in the application of matrix-free 
LDI-MS detection of peptides. In a typical experiment, the carbon nanospheres were 
dispersed in ethanol at a concentration of 10 mg/mL and 1 μL of the slurry was 
deposited on the plain steel plate. After drying under ambient condition, 0.2 μL of 
diluted molecule solutions (N-[1-(2,3-dioleoyloxy)-propyl]-N,N,N-
trimethylammonium methyl chloride, DOTAP) were added on the nanospheres 
followed by MS analysis. For MS analysis, the samples were directly analysed on a 
Bruker Autoflex TOF/TOF III Smart beam. All mass spectra were obtained in the RP-
HPC-Proteomics mode via an accumulation of 500 laser shots at 10 different sites 
under a laser intensity of 36% for data collection. Two standard peptides, Angiotensin 




Transmission electron microscopy (TEM) measurements were conducted on a JEM-
2100 F microscope (JEOL, Japan) operated at 200 kV. The samples for TEM 
measurement were suspended in ethanol and supported onto holey carbon film on a 
Cu grid. Scanning electron microscopy (SEM) was taken with a JEOL-6400 electron 
microscopy operating at 8 kV. The surface area of the hollow carbon spheres was 
measured with the Brunauer−Emmett−Teller (BET) method using nitrogen adsorption 
and desorption isotherms through a Micrometrics ASAP 2020 system. 
 
Figure 7.1 Schematic illustration of the synthesis process for hollow carbon spheres 





Figure 7.2 Typical large-scale SEM image and TEM images of silica nanospheres 
with an average size ~360 nm. 
 
Figure 7.3 a,d. SEM images; b,e. TEM images and c,f. HRTEM images of the 
silica@RF resin core-shell nanospheres with rough (a-c) and smooth (d-f) surface 
prepared by tuning the ratio of water/ethanol. 
 
7.3 The synthesis of raspberry-like hollow carbon spheres 
The preparation process has been schematically illustrated in Figure 7.1. First, 
negatively charged silica spheres with uniform size of ~ 360 nm were synthesized 
through the well known Stöber method (Fig. 7.2). Cetyltrimethylammonium bromide 
(CTAB) was employed for alternating the surface charge of silica spheres to positive 
for efficiently coating of the negatively charged RF onto silica surface through an 
electrostatic attractive force in the mixture of water and ethanol. The surface properties  
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can be well controlled by tuning the water/ethanol ratio (R), a critical factor to ensure 
the homogeneous nucleation and surface uniform coating. After polymerization of 
resorcinol and formaldehyde catalysed by ammonium hydroxide on the outside of 
silica spheres, uniformly monodispersed core–shell silica@RF spheres with rough or 
smooth surface can be controllably prepared by varying the ethanol/water ratio. 
Finally, HCCNs with either rough or smooth surface are obtained after the pyrolysis 
of the silica@RF and subsequent elimination of the silica core by 10% HF as illustrated 
in Figure 7.1.  
 
Figure 7.4 The effect of CTAB treatment to RF resin coating on the surface of silica. 
(a-b) no CTAB added; (c-d) 1 mL of CTAB added; and (e-f) 5 mL of CTAB added. 
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Figure 7.3 presents typical SEM and TEM images of the obtained core–shell 
structured silica@RF spheres. The silica@RF nanospheres prepared with R at 0.75 are 
highly monodisperse and spherical, with an average diameter of 470 nm and the 
surface is rough with raspberry-like morphology (Figs. 7.3a and 7.3b). The silica@RF 
composite particles possess a typical core–shell structure with a deep silica core and a 
light contrast of RF shell. The thickness of the raspberry-like shell is estimated to be 
about 20 nm for the concave surface and about 46 nm for the convex surface (Fig. 
7.3c). The silica@RF spheres with smooth surface can be synthesized with R at 1.33 
(Figs. 7.3d-f). The particle size is about 430 nm with shell thickness of 20 nm. The 
TEM image of silica@RF shows no free RF polymer nanospheres (Figs. 7.3b and e). 
CTAB plays a critical role to ensure the successful coating of RF resins on silica 
spheres for the formation of both smooth surface and rough surface. 
 
 
Figure 7.5 Shell thickness control by tuning the concentration of precursors. (a-c) shell 
thickness around 6 nm; (d-f) shell thickness around 20 nm; (g-i) shell thickness around 
75 nm.  
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    As shown in Figures 7.4a-c, without the addition of CTAB, only free RF resin 
particles can be observed. With increased concentration of CTAB, the RF resin shell 
is transferring to a more porous structure but the thickness of the shell has not been 
altered. Interestingly, we found that the thickness of the smooth shells of silica@RF 
increases gradually from 6 to 75 nm with increasing concentration of precursors (Fig. 
7.5). This result indicates that the resultant HCCNs shell thickness can be easily 
adjusted by altering the concentration of precursor. 
     
 
Figure 7.6 SEM (a, c), and TEM images (b, d) of hollow colloidal carbon 
nanostructures with either rough (a, b) or smooth surface. 
 
    A remarkable feature of the resorcinol-formaldehyde (RF) polymer is the high 
conversion yield to carbon (up to 62 wt%).[7, 9, 25, 32] Therefore, the as-obtained 
silica@RF core-shell nanostructures can be easily transformed to silica@C core-shell 
nanostructures after the carbonization process, which was completed by heat-treatment 
under N2 atmosphere at 350 and 600 °C for 2 and 4 h, respectively. To obtain the 
hollow colloidal carbon nanostructure, silica was finally removed in a diluted HF 
solution. Interestingly, the raspberry-like rough surface of the HCCNs was well 
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maintained. As shown in Figures 7.6a and 7.6b, the final product is in a hollow 
structure with a raspberry-like rough surface. During the carbonization process, the 
shell thickness shrunk. The thickness of the raspberry-like shell is estimated to be 
about 20-25 nm for the concave surface (originally around 30 nm) and about 40-45 nm 
for the convex surface (originally around 50 nm). Accordingly, the smooth surface has 
also been well maintained, as evidenced by Figures 7.6c and 7.6d. Although some 
broken pieces could be detected after treatment with HF solution, the overall shape 
was well maintained in both raspberry-like and smooth HCCNs, implying the robust 
nature of the as-prepared structures. As shown in Figure 7.7, the nitrogen adsorption-
desorption isotherms of both raspberry-like and smooth HCCNs are type I indicating 
their microporous structure. The measured surface areas of raspberry-like and smooth 
HCCNs are 456.62, and 387.71 m2/g, respectively. 
 
 







7.4 Formation mechanism 
 
 
Figure 7.8 SEM and TEM images of the silica@RF resins composites obtained with 
different water/ethanol volume ratio: Water/ethanol volume ratio=(a, b, c) 0:28; (d, e, 
f) 1:6; (g, h, i) 3:4; (j, k, l) 4:3;and (m, n, o) 5:2. 
 
    To investigate the formation mechanism of a RF resin coating on silica surface with 
different morphologies, a series of experiments has been conducted. We found that the 
ratio of water/ethanol (R) is a critical factor in determining the final morphology of 
RF resins. As shown in Figures 7.8a-c, when the reaction was performed in a pure 
ethanol system, silica-RF anisotropic particles with patchy and Janus architectures can 
be obtained, in which the surface is partially coated with some RF islands. When the 
water/ethanol ratio was gradually increased from zero to 0.17, although a fully dense 
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coating on the surface was not achieved, the silica surface was deposited with larger 
patchy RF particles (Fig. 7.8d-7.8f). When the water/ethanol ratio was further 
increased to 0.75, a raspberry-like rough RF coating on the silica surface was observed 
(Figs. 7.3a, b and 7.8g-i). From both SEM and TEM characterizations, the as-prepared 
silica@RF is very uniform. Based on the high-resolution TEM observation, the shell 
thickness is around 20 nm (concave part) to 46 nm (convex part). A smooth RF coating 
on silica surface could be obtained when the water/ethanol ratio is increased to 1.33, 
and the shell thickness is around 20 nm (Figs. 7.8j-7.8l). Further increasing the 
water/ethanol ratio to 2.50 does not impact the shell roughness or the shell thickness, 
as inspected from Figures 7.4m-7.4o, which is different from the previous report that 





Figure 7.9 Proposed formation mechanism of RF coating process in mixture solution 
of water and ethanol with different ratios.  
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    The different surface properties of the as-prepared silica@RF composite might be 
ascribed to the compatibility between the CTAB-modified silica surface and the 
solvent. After treatment with CTAB solution, the silica surface with negative charge 
was transferred to positive charge due to the adsorption of CTAB micelles. The 
optimized energies of CTAB tail in ethanol and water are -170.736 kJ/mol and -73.297 
kJ/mol, respectively, which indicates the solubility of CTAB in ethanol is higher than 
that in water, and the surface tension is higher.[33,34] As suggested previously,[32] 
ammonia can supply the positive charges (NH4+) out of RF polymer spheres surface 
to prevent the aggregation. Therefore, a higher ethanol content in the solution would 
inspire a higher CTAB solubility and a stronger surface tension and the system would 
provide more positive charges, resulting in the partial coating of RF resin on the 
surface with the formation of the isolated RF particles. On the contrary, with the 
addition of more water inside the solvent system, positive charge concentration will 
be diluted, leading to the formation of fumed RF resins shell. As a result, the 
morphology of the final product would be evolved gradually from a partial coating 
with RF resins particle islands, to raspberry-like rough surface, and eventually to a 
smooth surface as proposed in Figure 7.9. A competitive process between homogenous 
nucleation and uniform surface coating is proposed as the formation mechanism for 
raspberry-like morphology. The strategy reported here also provides a facile way to 
design and synthesize the Janus architectures. 
 
7.5 Biomedical applications 
    As ideal candidates for matrix-free laser desorption/ionization mass spectrometry 
(LDI-MS) analysis, carbon composites can eliminate background signals at low 
molecular range without the use of extra organic matrices thus providing better 
detection efficacy towards small bio-molecules (molecular weight < 1000 Da).[35-38]  
In order to investigate the performance of the prepared carbon nanospheres as 
substrates for LDI-MS analysis of small hydrophobic bio-molecules, a standard lipid 
molecule, DOTAP was employed (more details can be referred in the experimental 
section). As shown in Figure 7.10a, the fine-resolved ion peak of DOTAP (signal 
strength over 10,000) can be observed at the m/z of 662 ([C42H80NO4]+) consuming 30 
fmol of lipids only by the use of carbon nanospheres with rough surface as LDI 
substrates. By comparison, the signal strength of DOTAP is less than 4000 using the 
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carbon nanospheres with smooth surface (Fig. 7.10b), while no signals could be 
detected from DOTAP in control on the plain steel substrates (Fig. 7.10c). The above 
desorption/ionization performance of the carbon nanospheres with rough surface is 
superior to previously reported graphene/silica nanocomposites[35] and comparable 
to the best current results.[36] The merits of the rough carbon nanospheres are 
dependent on the enhanced surface roughness to capture the lipid molecule (comparing 
favourably to the smooth surface), nano-scaled particle size (470 nm) and high surface 
hydrophobicity in the scale of fmol), these carbon nanospheres are anticipated to be 




Figure 7.10 Laser desorption/ionization mass spectrometry (LDI-MS) analysis by 
using different materials as the matrix: (a) raspberry-like HCCNs; (b) smooth HCCNs; 
and (c) without carbon nanospheres. 
 
7.6 Conclusions 
    In conclusion, for the first time, we have successfully prepared hollow colloidal 
carbon nanostructures with raspberry-like morphology. This facile method is highly 
reproducible and straightforward to synthesise uniform hollow colloidal carbon 
137 
 
nanostructures with controllable surface properties and Janus particles. The 
water/ethanol ratio of the solvent is a critical factor in determining the different surface 
properties. After a thorough systematic investigation, we found the formation of 
different morphologies of silica@RF is due to the solubility difference of CTAB in 
different solvents, i.e., a lower solubility of CTAB in ethanol induced the formation of 
discrete RF resins. The roles playing by ammonia and CTAB for polymerizations in 
such synthetic system need further investigation. With the high carbon yield from the 
carbonization of RF resin, the as-prepared silica@RF can be transformed to a hollow 
carbon nanostructure with well-maintained morphology. Furthermore, the as-prepared 
raspberry-like HCCNs display superior performance to smooth HCCNs in the LDI-
MS detection of peptides, which has been ascribed to the different surface properties 
to capture the peptide molecule. However, the scaling up of current synthetic method 
is still a challenge due to the uncertainties brought in by the employed multi-step hard 
template processes. Future endeavour can be focusing on the development of a facile 
one step method for the synthesis of carbon nanomaterials with raspberry-like 
morphology. We believe that these carbon nanostructures could find their niche and 
contribute an added dimension in many possible application fields including sensors, 
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Chapter 8. Conclusions and perspectives  
8.1 Conclusions  
Multicomponent nanocomposites with tunable composition, structure, pore size, easy 
functionalization, possess many advantages for nanotheranostics applications. 
Although the design of multicomponent nanoparticles is still at its infancy, the 
formulation of multicomponent nanocomposite particles is particularly interesting and 
a crucial step for their administration. This thesis has been devoted to the development 
of the green and facile methods for the construction of multicomponent 
nanocomposites. Multicomponent nanocomposites with various compositions such as 
mesoporous silicas encapsulated Fe3O4 nanoparticles, Ag nanoparticles, silica and 
carbon spheres have been successfully prepared. In addition, porous silicas and 
carbons with hollow and raspberry-like spheres morphologies have been produced. 
Moreover, mild and green synthesis methods have been developed to fabricate silicas 
and silver nanoparticles. The developed multicomponent nanocomposites demonstrate 
a broad potential application in nanotherapeutics, for example, cellular drug/gene 
delivery, matrix free peptide detection and anti-bacterial. The major conclusions of 
this thesis can be summarised as following: 
 
8.1.1 Magnetic Fe3O4 and mesoporous silica core-shell nanospheres with tunable size 
and large void pore for cellular uptake 
 
 Multicomponent magnetic mesoporous silica core-shell nanospheres with large 
void pores and tunable particle sizes have been successfully synthesized by an 
extension of the Stöber process. The particle size can be tuned from 110 nm to 
800 nm by tailoring the ethanol to water volume ratio, while the large void pore 
on shell can be regulated from 8.0 to 20 nm by increasing the amount of ethanol.  
 
 The magnetic mesoporous silica core-shell nanospheres can be easily surface 
modified with an ammonia group; and the NH2-functionalized magnetic 
mesoporous silica nanospheres can be efficiently internalized into HeLa cell 




 The resultant multicomponent magnetic mesoporous silica core-shell 
nanospheres would provide an application paradigm of magnetic mesoporous 
silica nanoparticles for cell labelling and drug delivery.  
 
8.1.2 Inorganic-salts assisted self-assembly of Pluronic F127-organosilica into 
ordered mesostructures 
 
 A mild synthesis method has been developed for PMOs with hexagonal, body-
center cubic and face-center cubic mesostructures. Sodium bicarbonate 
(NaHCO3)/sodium carbonate (Na2CO3) buffer solution (pH≈9.9) provide a 
mild synthetic medium to slow down the formation process.  
 
 The influences of cationic metals of inorganic salts on the mesostructure of 
PMO materials have been systematically investigated.  It has been found that 
ordered body-center cubic mesotructured PMOs can be obtained by the 
assistance of MgSO4, NiSO4 and ZnSO4. The interaction between F127 
micelles and organosilicas has been enhanced by the inorganic sulfates. 
 
 The formation mechanism of mesoporous organosilicas has been explored and 
clarified on the basis of the micelles-organosilicates closed packing. 
Overcoming the problems encountered by the conventional method with fast 
hydrolysis and condensation process of organosilane, our synthetic strategy 
can be more facilely applied to investigate, monitor, and understand the 
formation process of mesoporous materials. 
 
8.1.3 Less is more, greener microbial synthesis of silver nanoparticles 
 
 A green microbial synthesis method has been developed for silver 
nanoparticles (AgNPs). It is found that AgNPs could be synthesized in several 
types of microorganism culture broth without any specific living microbe 
involvement. 
 
 Light and high pH values of broth were identified as two critical factors in 
ensuring pure AgNPs formation. In broths containing NaCl at high 
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concentration (0.5 wt%), silver chloride was identified as the major 
intermediate and could be converted to AgNPs via one-pot photoreduction. 
 Our broth alone strategy dramatically simplifies the conventional microbial
nano-synthesis process by cutting the use of microorganisms and thus provides
a more eco-friendly way for nano-Ag preparation. The fundamental
understanding of the microbial synthesis mechanisms and implementing of
complete green methods to fabricate technologically important nanomaterials
will be further promoted by this study.
8.1.4 One-pot synthesis of raspberry-like mesoporous silica nanospheres 
 This study developed a facile one-pot strategy to successfully prepare
raspberry like mesoporous silicas with particle size of 360 nm through an
extension of the Stöber process. By precisely controlling the synthesis
parameters, either decreasing the CTAB concentration or increasing the TEOS
amount, multi-compartment silicas with mesoporous silica spheres bridged
with mesoporous silica rods can be fabricated.
 We identify that by the control over the concentration of cationic surfactant
and silica precursor can be used to manipulate the multiple morphological
evolutions of mesoporous silica nanoparticles. It is found that the particle size
of mesoporous silica can be tuned from 100 to 600 nm by varying the water to
ethanol ratio.
 Our strategy allows an easy way to generate the hierarchical nanostructured
silicas by mimicking the structures of diatom cells for the potential application
in catalysis and nanomedicine. Further studies are currently in progress in order
to study their applications in gene therapy and anti-aging.
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8.1.5 Raspberry-like hollow carbon nanospheres with enhanced matrix-free peptide 
detection profiles 
 For the first time, resorcinol formaldehyde (RF) polymer resins have been
successfully coated on the silica spheres by the extension of Stöber method, to
generate raspberry-like silica@RF core-shell particles with a rough surface.
After carbonization of the shell and removal of silica, uniform raspberry-like
hollow carbon spheres were obtained.
 A competitive process between homogenous nucleation and uniform surface
coating is proposed as the mechanism for formation of the raspberry-like
morphology. By finely controlling the water/ethanol ratio, a series of hollow
carbon spheres with different surface properties and patchy structures can be
synthesized with this method.
 The raspberry-like hollow carbon spheres demonstrate much better
performance than hollow carbon spheres with a smooth surface in matrix-free
peptide detection due to their high capability to capture the small peptide
molecule.
    In summary, multicomponent nanocomposites particles with various compositions, 
surface properties and morphologies have been successfully prepared in this thesis. 
More greener and mild synthesis strategies have been developed. The resultant 
multicomponent nanocomposites have tunable composition, structure, pore size, 
functionality, demonstrate high biomolecular loading amount, increased cellular 
uptake performance and high biocompatibility. The biomedical applications of these 
multicomponent nanocomposites particles in siRNA delivery, gene therapy, anti-
bacteria and matrix-free peptide detection suggests the possibility to establish 
multicomponent nanocomposites platform for nanotheranostics. 
8.2 Perspectives and suggestions for future research 
The field of nanotheranostics, which is still in the early stages of its development, 
stands to benefit society greatly with the implementation of nanotechnology. We began 
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humbly by the design and development of multicomponent nanocomposites and their 
green and mild synthesis approaches. We have also shown that these multicomponent 
nanocomposites have potential applications in biomedical diagnosis and therapy. 
Although some progress has been achieved in the development of multicomponent 
nanocomposites for biomedical applications in this thesis. There are opportunities to 
extend the synthesis approaches to develop more complex multicomponent 
nanocomposites; and to exploit the multicomponent nanocomposites developed in this 
thesis for other biomedical applications, as exampled below. 
1. New facile, economic mild strategies for the synthesis of multicomponent
nanocomposites should be further explored for their large-scale production.
Therefore, it is of great importance to design multicomponent nanocomposites
for large-scale production and with a controlled structure and stable surface
chemistry.
2. In future studies, by combination of computational simulation and theoretical
modelling, combinatorial chemistry and high throughput screening
experimental methods, the synthesis of multicomponent nanocomposites can
be designed with precise located functionality.
3. Development of more precise in-situ techniques (in-situ Raman, in-situ FTIR,
in-situ TEM) or even a combination of these techniques, for the deep
understanding of the formation mechanism of multicomponent
nanocomposites.
4. More insights in understanding the effects of particle size, shape, porous
structure and surface chemistry on the deposition, uptake, translocation, and
toxicity of nanoparticles can be developed.
5. Using inorganic nanocarriers as building blocks, integrating therapeutic agents
(anticancer drugs, DNA, small interfering RNA [siRNA], proteins,
hyperthermia-inducing nanoparticles, ROS-generatingagents, etc.) and
imaging agents (e.g., organic dyes, quantum dots [QDs], upconversion
particles [UCNPs], MRI contrast agents, CT contrast agents, etc.) to generate
multifunctional nanocomposites systems while maintaining their individual
functional characteristics. These multifunctional nanocomposites are expected
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to endow advanced properties such as long circulation time, controlled release, 
drug and gene co-delivery, and eventually should be able to simultaneously 
realize diagnosis and therapeutics as a theranostic agent. 
6. It should also be pointed out that the current experiments in this study are
performed at a laboratorial scale. If the above issues are satisfactorily addressed
in the future, clinical translations of multicomponent nanocomposites as a new
platform for medical doctors for simultaneous diagnosis and the efficient and
specific treatment of diseases.
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